WO2019242047A1 - Recombinant spider silk proteins, preparation method therefor and industrial application thereof - Google Patents

Recombinant spider silk proteins, preparation method therefor and industrial application thereof Download PDF

Info

Publication number
WO2019242047A1
WO2019242047A1 PCT/CN2018/094616 CN2018094616W WO2019242047A1 WO 2019242047 A1 WO2019242047 A1 WO 2019242047A1 CN 2018094616 W CN2018094616 W CN 2018094616W WO 2019242047 A1 WO2019242047 A1 WO 2019242047A1
Authority
WO
WIPO (PCT)
Prior art keywords
spider silk
silk protein
protein
recombinant spider
repa
Prior art date
Application number
PCT/CN2018/094616
Other languages
French (fr)
Chinese (zh)
Inventor
马永
赵百学
王安良
孙文秀
江辰阳
Original Assignee
常州京森生物医药研究所有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 常州京森生物医药研究所有限公司 filed Critical 常州京森生物医药研究所有限公司
Publication of WO2019242047A1 publication Critical patent/WO2019242047A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06At least partially resorbable materials
    • A61L17/10At least partially resorbable materials containing macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10Polypeptides; Proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10Polypeptides; Proteins
    • A61L24/108Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18Manufacture of films or sheets
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/04Materials for stopping bleeding
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185Escherichia
    • C12R2001/19Escherichia coli

Definitions

  • the invention relates to a series of recombinant spider silk proteins, coding genes, expression and purification methods thereof, and the application of the recombinant spider silk proteins to medical products such as silk formation and nano-film formation.
  • Spider silk is as hard as steel and as elastic as rubber. Its outstanding performance is mainly manifested in: high strength, high elasticity, high work of fracture, can be said to be the toughest material so far, known as "biosteel". With the deepening of research on spider silk, it was found that spider silk also has characteristics such as biodegradability, super shrinkage, high temperature resistance, low temperature resistance, and compatibility with biological tissues. Because of its unique physical and biological properties, spider silk has a wide range of applications in medicine, materials, military and textiles. Swedish scientist Jan Johansson uses non-irritating chemicals to produce artificial spider silk with good biocompatibility. It can be used in spinal cord repair or helping stem cell growth to repair damaged heart tissue and other regenerative medicine research. It can also be used for self-protection. Appliances and other textile industry applications (Nature, Chemical, Biology, DOI: 10.1038 / nchembio. 2269).
  • spider silk protein In view of the huge potential applicability of spider silk protein, scholars at home and abroad have strengthened their research on spider silk, hoping that spider silk can be used in practice on a large scale like silk. Because spiders cannot be domesticated and natural spider silk has little output, genetic engineering can be used to obtain spider silk in large quantities to meet the potential application requirements of spider silk.
  • researchers can use the expression systems of E. coli, yeast, insect cells, mammalian cells and other expression systems for the bioengineering of spider silk proteins.
  • E. coli expression lines have multiple advantages such as fast growth, high yield, large scale production, low cost, simple culture conditions, and clear genetic background. They are currently widely used in the recombinant expression of spider silk proteins.
  • the molecular weight of natural spider silk is very large (> 300KDa), and the expression of Escherichia coli is greater than 60KDa, and the expression will decrease.
  • the natural molecular weight of natural spider silk is too large to be successfully expressed.
  • Fahnestock et al. Reported that spider traction silk protein was expressed in E. coli, but found that the expression efficiency of genes larger than 3 kb was reduced, and there was a phenomenon of gene abridged expression.
  • GPGXX (mainly two forms of GPGGx and GPGQQ) is a pentameric peptide, which mainly exists in traction silk proteins and flagellar silk proteins, forming a ⁇ -turn structure, and a series of ⁇ -turns are folded in series, similar to a spring structure. And this "spring" structure is related to the elasticity of spider silk protein, and the elasticity of spider silk protein is positively related to the content of the module.
  • GGX forms a 3 10 -helix structure, that is, every three amino acids make up a helix.
  • An / (GA) n forms a ⁇ -sheet structure.
  • the molecular action between the structural sheets determines the strength of the spider silk protein, which is also one of the reasons that causes the spider silk to be insoluble in water.
  • the spacer is a conserved region that separates glycine-rich regions.
  • (1) the chemical nature of spider silk is protein; (2) the amino acid sequence of spider silk protein is highly repetitive; (3) the amino acids in the spider silk protein are mainly alanine, glycine and serine; (4) It is rich in polyalanine and forms a ⁇ -sheet rigid structure; (5) ⁇ -ammonia corner structure formed by proline provides good elasticity for spider silk.
  • the primary structure of the recombinant spider silk protein contains the above-mentioned modules that determine the mechanical properties of the spider silk protein.
  • the sequence design can be personalized based on the research and development of different materials.
  • the artificial spider silk protein obtained through artificial sequence design not only has controllable mechanical properties, but also can control the molecular weight of the protein in order to achieve efficient expression of the protein in the E. coli expression system.
  • the inventors of the present application redesigned a series of protein sequences derived from natural spider silk, and simultaneously introduced a corresponding series of genes encoding recombinant spider silk protein sequences into host cells for protein expression, and established high efficiency Recombinant spider silk protein expression and preparation process. Based on this, the application of this series of recombinant spider silk proteins in electrospinning and wet spinning was studied.
  • the first object of the present invention is to provide a recombinant spider silk protein, which is composed of an N-terminal non-repeating region (N-NRT), a core repeating region (REP), and a C-terminal non-repeating region (C-NRT), wherein the core repeating region consists of 1 It consists of -30 RepA and / or 1-15 RepB.
  • N-NRT N-terminal non-repeating region
  • REP core repeating region
  • C-NRT C-terminal non-repeating region
  • RepA and RepB can use the tandem itself or the hybrid tandem of the two as the core repeat region.
  • the self-tandem is used as the core repeat region, it is preferable to contain 5-30 RepA as the core repeat region or 5-15 RepB as the core repeat region.
  • tandem of 1-5 RepA and 1-5 RepB is preferably used as the core repeat. More preferably, the tandem of 1-5 RepA is located near the N-terminal position of the entire fusion protein, and the tandem of 1-5 RepB is located at the C-terminal position of the entire fusion protein.
  • N-NRT N-terminal non-repeating region
  • C-NRT C-terminal non-repeating region
  • the inventors performed gene synthesis in the form of five tandems (RepA5), and also performed gene synthesis in the form of five tandems (RepB5).
  • RepA5 the form of five tandems
  • RepB5 the 5 ′ and 3 ′ ends of the nucleotides encoding RepA5 and RepB5 were introduced with homologous enzyme digestion sites BamHI and BglII, respectively.
  • the nucleotide sequences are codon optimized for the E. coli expression system, thereby increasing the expression in E. coli.
  • the tandem nucleotide sequence can be prepared by PCR or by gene synthesis.
  • the present invention also provides an expression vector containing the above-mentioned nucleotide sequence, as long as the vector matches the E. coli expression system, preferably a vector with a high copy number and high expression efficiency, such as pET21b, pET28a, pBV220 and the like.
  • the invention also provides an E. coli strain, preferably BL21 (DE3), BL21 (DE3) plys, Rosetta (DE3), Transetta (DE3), etc., comprising the expression vector described above.
  • the invention also provides a method for producing high-density fermentation of recombinant spider silk protein, which specifically includes: activation of fermented seeds, preparation of fermented first-stage seed liquid, preparation of fermented second-stage seeds, and high-density fermentation.
  • the high-density fermentation specifically includes the following steps:
  • the components of the batch fermentation medium include: 0.5-3 g / L of citric acid monohydrate, 8-15 g / L of potassium dihydrogen phosphate, 3-7 g / L of diammonium hydrogen phosphate, 10-20 g / L of glucose or 15 containing glycerin -30g / L, magnesium sulfate heptahydrate 1-3g / L.
  • a 1/1000 (V / V) trace element mother liquor is added to the batch fermentation medium to maintain the normal growth and metabolism of the bacteria.
  • the main components of the feed medium include: 1024g / L of glycerin, 10-20g / L of magnesium sulfate heptahydrate, and 30-60g / L of yeast powder. Before the start of feeding, 1/1000 must be added to the feed medium. (V / V) trace element mother liquor is used to maintain normal growth and metabolism of bacteria.
  • the components of the trace element mother liquid include: FeSO 4 .7H 2 O 10g / L, ZnSO 4 .7H 2 O 2.25g / L, CuSO 4 .5H 2 O 15g / L, MnSO 4 .5H 2 O 5g / L, CaCl 2 .7H 2 O 1g / L, CoCl.6H 2 O 1g / L, Na 2 MoO 4 .2H 2 O 1.125g / L, H 3 BO 3 0.0625g / L, HCl 41.75ml, Biotin 0.5g / L.
  • the method for activating the fermented seeds is specifically: inoculating the constructed recombinant spider silk protein E. coli strain cryopreservation tube into a LB solid medium using a three-zone streaking method, and incubating at 37 ° C overnight for activation.
  • the method for preparing the first-stage fermented seed liquid is specifically: picking a single colony with a full shape and a moderate size from a solid medium and inoculating it into the LB liquid medium, and culturing at 37 ° C and 220 rpm for 8-10 hours in a shaker. Seed liquid.
  • the method for preparing the fermented secondary seeds is specifically: transferring the primary seed liquid into a fresh LB liquid medium according to an inoculation amount of 1%, and culturing at 37 ° C and 220 rpm in a shaker to between OD 600 ⁇ 3-5, This is a secondary seed liquid preparation.
  • Any of the above vessels and culture media used for bacterial culture should be filtered or humid-heat sterilized before use, and any culture medium should be added with kana mold at a final concentration of 50 ⁇ g / ml before use after cooling after sterilization. To ensure thoroughbred culture.
  • the invention also provides a method for purifying recombinant spider silk protein, including the following steps:
  • step 3 Collect the supernatant of the bacterial lysate collected in step 2 by centrifugation, and put it in a water bath preheated to 75 ° C for 10-50min. The process of incubation should be continuously and gently stirred. This process is called Heat treatment of cell lysate.
  • the inventors of the present application optimized a series of new spider silk protein sequences based on the reported amino acid sequences of spider silk proteins and the relationship between the structural characteristics and function of the spider silk proteins. Features in one. In addition, these sequences were respectively introduced into E. coli by genetic engineering technology and the corresponding high-density fermentation process was established to successfully achieve efficient prokaryotic soluble expression of spider silk proteins.
  • the designed spider silk protein is often designed to consider the amount of preparation under the premise of ensuring performance.
  • the past design Spider silk protein has innate shortcomings, and even if it can obtain pure products, it needs to pay a huge investment.
  • the inventors have designed a series of spider silk proteins that can be expressed soluble in the prokaryotic system according to the properties of the spider silk protein. After purification, the purity of the recombinant spider silk protein (electrophoretic purity) can reach about 95%.
  • the silk protein series of arachnoid membrane and arachnid fiber prepared through the static spinning or wet spinning process can have a mechanical strength of 2.5-6MPa and 40-280MPa, and have good cell compatibility and hemostatic effect, which can be fully satisfied.
  • the special requirements in the medical field have the value of further development.
  • FIG. 2-1 Electrophoretic detection of RepA5 purified sample, where M: protein molecular weight standard; lane1: RepA5 purified sample electrophoresis;
  • FIG. 2-5 Electrophoretic detection of RepB10 purified sample, where M: protein molecular weight standard; lane1: RepB10 purified sample electrophoresis;
  • FIG. 2-6 Electrophoretic detection of RepB15 purified sample, where M: protein molecular weight standard; lane1: RepB15 purified sample electrophoresis;
  • FIG. 2-7 Electrophoretic detection of RepA5RepB5 purified sample, where M: protein molecular weight standard; lane1: RepA5RepB5 purified sample electrophoresis;
  • FIG. 2-8 Electrophoresis detection of RepB5 metal ion chelate chromatography purified sample, where M: protein molecular weight standard; lane1: before chromatography purification; lane2: chromatography purification penetration; lane3-4: chromatography purification elution sample;
  • FIG. 3 Scanning electron microscopy image of the electrospinning sample of recombinant spider silk protein, where the first: RepA5, the second: RepA10; the third: RepA20; the first: RepB5; the second: RepB10; the third: RepB15; the next: RepA5RepB5; Next two: RepA5RepB5-RepA5RepB5
  • Figure 4 Mechanical test results of the electrospun fiber membrane of the recombinant spider silk protein, wherein the samples of the recombinant spider silk protein corresponding to Figure 4-1 to Figure 4-8 in this order are: RepB5, RepB10, RepB15, RepA5, RepA10, RepA20, RepA5RepB5, RepA5RepB5 -RepA5RepB5
  • Figure 5 Mechanical properties of the wet-spun fiber of recombinant spider silk protein.
  • Figures 5-1 to 5-6 show the results of the mechanical properties of the RepB5, RepB10, RepB15, RepA5, RepA10, and RepA20 wet-spun fibers.
  • Fig. 6 Electron microscopic observation of the wet-spun fiber of recombinant spider silk protein.
  • Fig. 6-1 is an electron microscopy of the RepA5 wet-spinning.
  • Fig. 6-2 is a cross-sectional observation of the RepA5 fiber.
  • FIG. 7 Attachment effect of mouse fibroblasts (L929) on recombinant spider silk protein electrospun fiber membrane and bovine Achilles tendon collagen (type I) membrane, where 7-1 is collagen membrane, 7-2 RepB5 protein membrane;
  • the invention relates to the construction of multiple recombinant spider silk protein strains.
  • the splicing of repeat modules (repeat modules refer to RepB5 and RepA5) is achieved by molecular manipulation of isotail enzymes.
  • the scheme flow is shown in Figure 1.
  • the following describes the hybrid tandem (RepA5RepB5) formed by the tandem of RepA5 and RepB5 as an example, as follows:
  • RepA5 and RepB5 artificial nucleotide sequences were cloned into pUC57 plasmid, respectively, to form recombinant plasmids pUC57-RepA5 and pUC57-RepB5.
  • N-NRT and C-NRT gene sequences (such as SEQ ID NO: 16 and SEQ ID NO: 17), where the 5 'end of N-NRT contains the XbaI digestion site and the 3' end Contains BamHI digestion site (this digestion site is part of the N-NRT recombination nucleotide, does not change the amino acid sequence of N-NRT); C-NRT 5 'end contains BglII digestion site (the digestion As a part of the N-NRT recombination nucleotide, it does not change the amino acid sequence of N-NRT), the 3 'end contains XhoI digestion site; the nucleotide corresponding to N-NRT and C-NRT is synthesized in a fusion form , Which is N-NRT-C-NRT (5 ' ⁇ 3').
  • N-NRT-C-NRT was inserted into pET28aplus vector (recombined by removing the original BglII from pET28a original vector) by enzyme digestion and enzymatic ligation, and recorded as pET28aplus-N-NRT-C-NRT.
  • pUC57-RepA5 and pUC57-RepB5 were digested with BamHI and BglII to obtain RepA5 and RepB5 fragments with corresponding sticky ends.
  • PET28aplus-N-NRT-C-NRT was digested with BamHI and BglII to obtain a vector backbone fragment with corresponding sticky ends.
  • the viscous fragment obtained by enzymatic digestion was ligated and transformed into E. coli Transetta (DE3) to form a recombinant expression strain.
  • step 4 Pick a single clone from the transformation plate in step 4 for culture, extract the plasmid and use BamHI and BglII to digest and identify, and analyze and identify the positive clones obtained according to the principle of cleavage of the same tail.
  • the positive clones are Transetta (DE3).
  • the corresponding positive plasmids are pET28aplus-N-NRT-RepA5-C-NRT and pET28aplus-N-NRT-RepB5-C-NRT.
  • pET28aplus-N-NRT-RepA5-C-NRT was digested with BglII to obtain a vector backbone fragment with corresponding sticky ends
  • pUC57-RepA5 was digested with BamHI and BglII to obtain a RepA5 fragment with corresponding sticky ends.
  • the two cohesive fragments were ligated and transformed into E. coli Transetta (DE3) to form a recombinant expression strain. After identification, Transetta (DE3) -RepA10 (a tandem containing 10 RepA) was obtained.
  • the corresponding positive plasmid was pET28aplus-N-NRT.
  • -RepA10-C-NRT was obtained.
  • pET28aplus-N-NRT-RepA10-C-NRT can be repeatedly operated to obtain a tandem containing n RepA5 (such as a tandem containing 5, 10, 20, 30 ... RepA) recombinant E. coli strain, That is Transetta (DE3) -n ⁇ RepA5.
  • the positive clone obtained was analyzed and identified according to the principle of cleavage of the same tail enzyme.
  • the positive clone was Transetta (DE3) -RepA5RepB5.
  • the positive plasmid was pET28aplus-N-NRT-RepA5-RepB5-C-NRT.
  • Spider silk protein contains a large number of repetitive amino acid sequences. This characteristic causes it to encounter problems such as depletion of the tRNA pool, obstacles to gene replication, truncation of protein translation, etc., resulting in low expression levels. Studies have shown that as the molecular weight of artificial spider silk protein increases (greater than 60KDa), the expression of the protein will increase greatly, and the problem of expression failure may occur. The molecular weight of natural spider silk protein can reach more than 200KDa. Although there is no direct research showing that the molecular weight of spider silk protein is directly proportional to its mechanical properties, it is still necessary to make the artificially designed spider silk protein as close as possible to the natural spider silk protein in molecular weight. similar.
  • the recombinant spider silk protein must balance molecular weight with the expression of E. coli. If the molecular weight is too large, the expression will be reduced or the expression will fail. If the molecular weight is too small, the biomimetic degree of the natural sequence will be low.
  • This section describes the inventor's high-density fermentation process for recombinant spider silk protein, which is illustrated by the fermentation process of Transetta (DE3) -RepA20 (The molecular weight of RepA20 in the spider silk protein construct in Example 1 is relatively large, reaching 88 KDa The evaluation of process yield is representative.
  • the prepared secondary seed liquid is inoculated into the fermentation medium to start feeding-batch high-density fermentation culture.
  • the high-density fermentation process can realize the large-scale expression of recombinant spider silk protein.
  • the components of the batch fermentation medium include: 1.7 g / L of citric acid monohydrate, 12 g / L of potassium dihydrogen phosphate, 4 g / L of diammonium hydrogen phosphate, 30 g / L of glycerin, 1.2 g / L of magnesium sulfate heptahydrate, Before fermentation inoculation, a 1/1000 (V / V) trace element mother liquor is added to the batch fermentation medium to maintain the normal growth and metabolism of the bacteria.
  • the trace element mother liquor components include: FeSO 4 .7H 2 O 10g / L, ZnSO 4 .7H 2 O 2.25g / L, CuSO 4 .5H 2 O 15g / L, MnSO 4 .5H 2 O 5g / L, CaCl 2 .7H 2 O 1g / L, CoCl.6H 2 O 1g / L, Na 2 MoO 4 .2H 2 O 1.125 g / L, H 3 BO 3 0.0625 g / L, HCl 41.75 ml, Biotin 0.5 g / L.
  • the main components of the feed medium include: 1024 g / L of glycerin, 20 g / L of magnesium sulfate heptahydrate, and 50 g / L of yeast powder.
  • the above-mentioned trace element mother liquor of 1/1000 (V / V) is added to the feeding medium to maintain the normal growth and metabolism of the bacteria.
  • the steps of the high-density fermentation method include: inserting the prepared secondary seed liquid into a sterilized fermentation tank according to an inoculation amount of 5-15% ⁇ setting the fermentation temperature to 37 ° C and the pH to 6.8-7.0
  • the DO is set between 30-40% (controlled by the speed / air / high-purity oxygen correlation) ⁇ regular sampling after the start of fermentation to measure OD 600 and the wet weight of the bacteria, until the DO curve shows a sharp rise It indicates that the glucose in the batch medium is depleted, and the feed culture is started (the flow acceleration of the feed medium is maintained at 12 g / L / h (feed medium quality / fermentation liquid initial volume / time)) ⁇ wait for bacteria When the body grows to between 0D 600 ⁇ 40-55, reduce the fermentation temperature to 30 ° C. After the temperature is stabilized, add IPTG with a final concentration of 0.5 to the fermentor to induce expression ⁇ induce the expression and end the culture 6h.
  • any of the above vessels and culture media used for bacterial culture should be filtered or humid-heat sterilized before use, and any culture medium should be added with kana mold at a final concentration of 50 ⁇ g / ml before use after cooling after sterilization.
  • the recombinant spider silk protein contains a large number of amino acid repeats.
  • the strain obtained in Example 1 can achieve effective expression using this high-density fermentation process, and some strains can reach more than 0.5 g / L, which lays the foundation for the large-scale application of recombinant spider silk.
  • This section describes the non-chromatographic protein purification method of spider silk protein.
  • the purity of the recombinant spider silk protein (electrophoretic purity) can reach more than 75%. It needs to be clear that its residual impurities are important for subsequent Spinning and other operations have no obvious impact, and the pure spider silk protein can meet most industrial applications.
  • the artificial spider silk protein in the present invention contains a 6 ⁇ His tag at the N-terminus, and the designed molecule is soluble, the artificial spider silk protein in this patent can be more purified by IMAC affinity chromatography.
  • the electrophoretic purity is above 95%, which meets the requirements of refining and purification, and can completely meet the needs of special applications such as medical treatment.
  • the fermented bacterial cells prepared in Example 2 are respectively processed by simple purification and refining purification processes, and the specific purification operations are as follows:
  • step 3 Collect the supernatant of the bacterial lysate collected in step 2 by centrifugation, and place it in a water bath preheated to 75 ° C for 20 minutes. During the heat preservation process, continuous gentle stirring is required. This process is called bacterial cells. Thermal treatment of lysate.
  • step 5 Add the supernatant after the filtration treatment in step 4 to a 3M aqueous ammonium sulfate solution for salting out. Add ammonium sulfate slowly, and the salting-out system is in a state of rapid stirring and mixing. With the addition of ammonium sulfate, when the salting-out system appears turbid, stop adding ammonium sulfate, and place the salting-out system at 4 ° C with stirring for 5 h.
  • step 5 Centrifuge the salting-out system in step 5 to collect the salting-out precipitate.
  • the precipitate contains artificial spider silk protein.
  • the artificial spider silk protein salted-out precipitate in step 6 is repeatedly washed with a 20-50% ethanol aqueous solution until the ammonium sulfate is substantially removed (the conductivity of the washing solution is not higher than 0.05 mS / cm), and then collected The spider silk protein is precipitated, and the spider silk protein raw material is obtained after lyophilizing the protein.
  • Example 2 A part of the precipitated protein was taken for SDS-PAGE analysis using the method in Example 1. The analysis result is shown in FIG. 2.
  • the electrophoresis detection results were obtained by using gray scale analysis of various artificial spider silk proteins to obtain electrophoretic purity of more than 75%.
  • the final protein collected by centrifugation can be dried by freeze drying, hot air drying, spray drying and other methods to obtain purified spider silk protein. After drying, the spider silk protein is weighed, and the recombinant spider silk protein is calculated based on the purity and fermentation volume.
  • the fermentation yield of RepA20 was 0.45 g / L.
  • the inventor also selected RepB5 for the purification research of IMAC affinity chromatography.
  • the affinity chromatography uses the sample heated in step 4 of this example as the initial sample to be purified (EDTA should be removed from the sample).
  • Purification method Refer to Gehealthcare's purification scheme for nickel ion chelate chromatography.
  • the electrophoretic analysis of the purified sample is shown in Figure 2-8. According to the analysis, the target protein can be effectively combined with the chromatographic packing, and the electrophoretic purity can be more than 95% after purification, which meets the requirements of purification.
  • Example 2 The applicant used the fermentation and purification processes of Example 2 and Example 3 to ferment and purify the partially constructed recombinant spider silk protein E. coli strain, respectively. Based on the results calculation, the protein expression levels of different recombinant spider silk protein strains are shown in Table 2 As shown.
  • the spinning dope Take 2ml of the spinning dope and add it to the syringe.
  • Select the 27G needle as the injection needle set the injection rate to 1ml / h, set the voltage to 16KV, set the receiving distance to 15cm, and the width of the spinning head to the left and right. 8-12cm, the receiving substrate is tin foil, and the fiber membrane is prepared by electrostatic spinning.
  • the fiber membrane prepared by the above-mentioned electrospinning was detected and analyzed using a scanning electron microscope, and the analysis result is shown in FIG. 3.
  • the fiber membrane prepared in step 2 is cut with a cutter (to remove the edge part of the spinning radiation) into a strip shape with a width of 1 cm.
  • step 2 Remove the foam from the spinning solution in step 1, and then inject it into a 1ml syringe. Use a 27G injection needle to push it out of the syringe. The spinning solution is squeezed out of the needle and dipped in ethanol to be solidified to form fiber filaments.
  • step 3 Take out the solidified fiber filament in step 2 and stretch it for 3-5 times in 80 ° C steam, and then expose it to 150 ° C for 30s to obtain mature fiber filament.
  • the fiber filament prepared by the method has a relatively regular cylindrical shape, the surface is smooth with obvious grooves, and the tensile fracture surface is relatively dense. Compared with the mechanical strength (40-280 MPa) of artificial recombinant spider silk fiber filaments reported at present, the mechanical strength of the fiber filaments corresponding to several recombinant spider silk proteins designed by the inventors belongs to a higher level.
  • the recombinant spider silk protein fiber membrane prepared by the inventor's electrospinning method has the characteristics of an electrospun fiber membrane in physical appearance. Therefore, in order to evaluate the biological compatibility of the fiber membrane, we used human umbilical cord blood mesenchyme Adhesion and appreciation of MSCs and mouse fibroblasts (L929) were evaluated. At the same time, it is recognized in the industry that natural collagen has excellent biocompatibility, is beneficial to skin repair and coagulation, and is reflected in the characteristics of promoting cell attachment and value-added. Therefore, we used bovine Achilles tendon collagen in the experiments. Comparison of electrospun membranes.
  • the fiber membrane fixed in step 1 is cut into a suitable size according to the diameter of the cell culture dish hole to ensure that the fiber membrane can evenly and completely cover the bottom of the culture dish.
  • a small amount of the cell suspension was placed in a 1.5 ml centrifuge tube. Use a blood cell count. Plates are counted. This was prepared as a cell suspension of 4 ⁇ 10 4 cells / ml. In a 24-well plate, wells with and without membranes are plated, and 200 ul of cell suspension is added to each well followed by 300 ⁇ l of medium for culture.
  • the recombinant spider silk protein fiber membrane can achieve cell attachment and growth faster, and therefore has good biocompatibility.
  • Skin wound repair and regeneration is an important potential field of application for electrospun fiber membranes.
  • the inventors evaluated recombinant spider silk protein fiber membranes prepared with electrospinning method together with natural collagen membranes in skin wound repair. Role, specific evaluation methods and results are as follows:
  • Animal model establishment Using the method of self-control, the rats selected three circular areas with a diameter of 12 mm at equal distances at about 0.5 cm on both sides of the spine, and each point was separated by 1 cm. Rats were injected intraperitoneally with a 10% chloral hydrate solution at a dose of 3.0 mL / kg. After the normal reflection disappeared, the full-thickness skin tissue was peeled off from the circular area and covered with the test product RepB5 and the bovine Achilles tendon collagen fiber membrane. After the experiment, each patient was injected with 2.0 ⁇ 10 3 U / d ampicillin sodium for 3 consecutive days to prevent infection. Wound healing was observed after surgery. Rats were euthanized at 3 weeks after operation. Digital images of the surgical site were collected and the area of the wound / hairless area of the surgical department was calculated using software to investigate the role of each group of samples in promoting wound healing. The results are shown in the figure below. 9 shown.
  • Example 8 In vitro coagulation test of recombinant spider silk protein
  • the relatively high-end medical coagulation products on the market include powdered natural collagen, which has the characteristics of rapid coagulation and biosafety. Therefore, the inventors also investigated the in vitro coagulation effect of recombinant spider silk protein compared with natural collagen, as follows:
  • Raw material acquisition Reconstituted spider silk protein lyophilized powder and bovine Achilles tendon collagen samples were crushed and powdered under the same conditions, and passed through a 50-mesh sieve to obtain a uniform powdery test product with substantially uniform particle size.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Insects & Arthropods (AREA)
  • Vascular Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Manufacturing & Machinery (AREA)
  • Analytical Chemistry (AREA)
  • Mechanical Engineering (AREA)

Abstract

Disclosed by the present invention are a recombinant spider silk protein series, coding genes thereof, expression and purification methods therefor, and an application of the recombinant spider silk protein series in biological materials such as sutures, bioremediation films and hemostatic materials. The recombinant spider silk protein series described in the present invention is composed of an N-terminal non-repeat region (N-NRT), a core repeat region (REP), and a C-terminal non-repeat region (C-NRT), wherein the core repeat region is composed of 1-30 RepAs and/or 1-15 RepBs, a single RepA amino acid sequence as shown in SEQ ID NO: 1, and a single RepB amino acid sequence as shown in SEQ ID NO: 2. The series of novel spider silk proteins for prokaryotic system soluble expression as designed by the present invention has high fermentation yield and high protein purity, spider silk membranes and spider silk fibers prepared from the spider silk protein series by means of a simple static spinning or wet spinning process have a mechanical strength of 2.5-6 MPa and 40-280 MPa respectively, and exhibit good cell compatibility and hemostatic properties, thus having prospects for industrial application in the medical field.

Description

重组蜘蛛丝蛋白及其制备方法和产业化应用Recombinant spider silk protein, preparation method and industrial application thereof 技术领域Technical field
本发明涉及一类重组蜘蛛丝蛋白系列,及其编码基因、表达、纯化方法,以及所述重组蛛丝蛋白系列在成丝、成纳米膜等医用制品方面的应用。The invention relates to a series of recombinant spider silk proteins, coding genes, expression and purification methods thereof, and the application of the recombinant spider silk proteins to medical products such as silk formation and nano-film formation.
背景技术Background technique
蜘蛛丝既有钢般的坚硬,又有橡胶般的弹性。其突出的性能主要表现在:高强度、高弹性、高断裂功,可以说是迄今为止最强韧的材料,被誉为“生物钢”。随着对蜘蛛丝的研究深入,发现蜘蛛丝还具有生物可降解性、超收缩性、耐高温、耐低温及与生物组织的相容性等特性。由于蜘蛛丝这些独特的物理和生物学特性,它在医学、材料、军事和纺织等方面都有着广泛的应用前景。瑞典科学家Jan Johansson利用无刺激性化学物质制造出的人工蜘蛛丝具有良好的生物相容性,可应用于脊髓修复或帮助干细胞生长来修复损伤的心脏组织等再生医学研究中,亦可用于自身防护用具等纺织工业应用中(Nature Chemical Biology,DOI:10.1038/nchembio.2269)。Spider silk is as hard as steel and as elastic as rubber. Its outstanding performance is mainly manifested in: high strength, high elasticity, high work of fracture, can be said to be the toughest material so far, known as "biosteel". With the deepening of research on spider silk, it was found that spider silk also has characteristics such as biodegradability, super shrinkage, high temperature resistance, low temperature resistance, and compatibility with biological tissues. Because of its unique physical and biological properties, spider silk has a wide range of applications in medicine, materials, military and textiles. Swedish scientist Jan Johansson uses non-irritating chemicals to produce artificial spider silk with good biocompatibility. It can be used in spinal cord repair or helping stem cell growth to repair damaged heart tissue and other regenerative medicine research. It can also be used for self-protection. Appliances and other textile industry applications (Nature, Chemical, Biology, DOI: 10.1038 / nchembio. 2269).
鉴于蜘蛛丝蛋白巨大的潜在应用性,国内外学者加强对蜘蛛丝的研究,希望蜘蛛丝能够像蚕丝那样大规模地应用于实际。由于蜘蛛无法驯养和天然蜘蛛丝产量少等原因,惟有通过基因工程手段才能大量获取蜘蛛丝,满足蜘蛛丝潜在的应用需求。目前研究人员可以借助大肠杆菌,酵母,昆虫细胞,哺乳动物细胞等表达系统进行蜘蛛丝蛋白的生物工程制备。其中,大肠杆菌表达系具有生长快、产量高、生产规模大、成本低、培养条件简单、遗传背景清楚等多重优点,目前被广泛应用于蜘蛛丝蛋白的重组表达研究中。但是,天然蜘蛛丝分子量非常大(>300KDa),而大肠杆菌表达的外源蛋白大于60KDa时就会出现表达量降低的现象,天然的蜘蛛丝蛋白分子量过大,几乎不可能表达成功。例如:Fahnestock等人就报道了在大肠杆菌中表达了蜘蛛牵引丝蛋白,但发现大于3kb的基因表达效率降低,并有基因删节表达现象。In view of the huge potential applicability of spider silk protein, scholars at home and abroad have strengthened their research on spider silk, hoping that spider silk can be used in practice on a large scale like silk. Because spiders cannot be domesticated and natural spider silk has little output, genetic engineering can be used to obtain spider silk in large quantities to meet the potential application requirements of spider silk. At present, researchers can use the expression systems of E. coli, yeast, insect cells, mammalian cells and other expression systems for the bioengineering of spider silk proteins. Among them, E. coli expression lines have multiple advantages such as fast growth, high yield, large scale production, low cost, simple culture conditions, and clear genetic background. They are currently widely used in the recombinant expression of spider silk proteins. However, the molecular weight of natural spider silk is very large (> 300KDa), and the expression of Escherichia coli is greater than 60KDa, and the expression will decrease. The natural molecular weight of natural spider silk is too large to be successfully expressed. For example, Fahnestock et al. Reported that spider traction silk protein was expressed in E. coli, but found that the expression efficiency of genes larger than 3 kb was reduced, and there was a phenomenon of gene abridged expression.
研究表明,蜘蛛丝蛋白有四种通用的氨基酸模块:(l)GPGXX;(2)GGx;(3)An/(GA)n;(4)间隔区(spacer)。GPGXX(主要是GPGGx和GPGQQ两种形式)是一个五聚肽,主要存在于牵引丝蛋白和鞭毛丝蛋白,形成β成转角结构,一系列的β系转角串联折叠在一起,类似弹簧结构。而这个“弹簧”结构与蜘蛛丝蛋白的弹性相关,蛛丝蛋白弹性的大小与该模块的含量正相关。GGX形成3 10-螺旋结构,即每三个氨基酸组成一个螺旋。An/(GA)n形成β成片层结构,结构片层之间的分子作用决定了蜘蛛丝蛋白的强度,也是导致蜘蛛丝不溶于水的原因之一。间隔区 是一个保守区域,用来间隔富含甘氨酸的区域。总的来说:(l)蜘蛛丝的化学本质是蛋白质;(2)蜘蛛丝蛋白氨基酸序列高度重复性;(3)蜘蛛丝蛋白中含量较多的氨基酸主要为丙氨酸、甘氨酸和丝氨酸;(4)富含聚丙氨酸,形成β成片层刚性结构;(5)脯氨酸形成的β氨转角结构为蜘蛛丝提供良好的弹性。 Studies have shown that spider silk proteins have four universal amino acid modules: (1) GPGXX; (2) GGx; (3) An / (GA) n; and (4) spacer. GPGXX (mainly two forms of GPGGx and GPGQQ) is a pentameric peptide, which mainly exists in traction silk proteins and flagellar silk proteins, forming a β-turn structure, and a series of β-turns are folded in series, similar to a spring structure. And this "spring" structure is related to the elasticity of spider silk protein, and the elasticity of spider silk protein is positively related to the content of the module. GGX forms a 3 10 -helix structure, that is, every three amino acids make up a helix. An / (GA) n forms a β-sheet structure. The molecular action between the structural sheets determines the strength of the spider silk protein, which is also one of the reasons that causes the spider silk to be insoluble in water. The spacer is a conserved region that separates glycine-rich regions. In general: (1) the chemical nature of spider silk is protein; (2) the amino acid sequence of spider silk protein is highly repetitive; (3) the amino acids in the spider silk protein are mainly alanine, glycine and serine; (4) It is rich in polyalanine and forms a β-sheet rigid structure; (5) β-ammonia corner structure formed by proline provides good elasticity for spider silk.
研究人员可以依据上述蜘蛛丝蛋白特性设计重组的蜘蛛丝蛋白,重组蜘蛛丝蛋白一级结构含有上述决定蜘蛛丝蛋白力学性能的模块,并且可以根据不同材料的研发用途进行个性化的序列设计,这样通过人工的序列设计获得的人工蛛丝蛋白不仅具有力学性能可控性而且可以控制蛋白分子量以便实现蛋白在大肠杆菌表达系统中的高效表达。Researchers can design recombinant spider silk proteins based on the characteristics of the spider silk protein. The primary structure of the recombinant spider silk protein contains the above-mentioned modules that determine the mechanical properties of the spider silk protein. The sequence design can be personalized based on the research and development of different materials. The artificial spider silk protein obtained through artificial sequence design not only has controllable mechanical properties, but also can control the molecular weight of the protein in order to achieve efficient expression of the protein in the E. coli expression system.
申请人经过研究发现,在既有的蛛丝蛋白设计方案和制备工艺的基础上,虽能满足一般工业领域应用所需,但在医疗制品等领域不仅需要常规的拉力强度,更需要高纯度、低免疫原性等应用需求时却无法满足。The applicant found that based on the existing spider silk protein design scheme and preparation process, although it can meet the needs of general industrial applications, in the fields of medical products, not only the conventional tensile strength, but also high purity, Application requirements such as low immunogenicity cannot be met.
发明内容Summary of the Invention
为克服上述技术问题,本申请发明人重新设计了一系列衍生自天然蜘蛛丝的蛋白序列,同时将对应的一系列编码重组蜘蛛丝蛋白序列的基因导入到宿主细胞中进行蛋白表达,并建立高效的重组蜘蛛丝蛋白表达和制备工艺。在此基础上研究了该类重组蜘蛛丝蛋白系列在静电纺丝和湿法纺丝中的应用。In order to overcome the above technical problems, the inventors of the present application redesigned a series of protein sequences derived from natural spider silk, and simultaneously introduced a corresponding series of genes encoding recombinant spider silk protein sequences into host cells for protein expression, and established high efficiency Recombinant spider silk protein expression and preparation process. Based on this, the application of this series of recombinant spider silk proteins in electrospinning and wet spinning was studied.
本发明第一目的在于提供重组蜘蛛丝蛋白,其由N末端非重复区域(N-NRT)、核心重复区域(REP)、C末端非重复区域(C-NRT)组成,其中核心重复区域由1-30个RepA和/或1-15个RepB组成,单个RepA氨基酸序列如SEQ ID NO:1所示,单个RepB氨基酸序列如SEQ ID NO:2所示。The first object of the present invention is to provide a recombinant spider silk protein, which is composed of an N-terminal non-repeating region (N-NRT), a core repeating region (REP), and a C-terminal non-repeating region (C-NRT), wherein the core repeating region consists of 1 It consists of -30 RepA and / or 1-15 RepB. A single RepA amino acid sequence is shown in SEQ ID NO: 1, and a single RepB amino acid sequence is shown in SEQ ID NO: 2.
RepA和RepB可以以自身串联体或者两者的杂交串联体作为核心重复区。以自身串联体作为核心重复区时,优选含有5-30个RepA作为核心重复区或者含有5-15个RepB作为核心重复区。RepA and RepB can use the tandem itself or the hybrid tandem of the two as the core repeat region. When the self-tandem is used as the core repeat region, it is preferable to contain 5-30 RepA as the core repeat region or 5-15 RepB as the core repeat region.
以两者杂交串联体作为核心重复区时,优选1-5个RepA与1-5个RepB的串联体作为核心重复区。更优选地所述1-5个RepA的串联体位于整个融合蛋白的靠近N端位置,而所述1-5个RepB的串联体位于整个融合蛋白的C端位置。When the hybrid tandem is used as the core repeat, a tandem of 1-5 RepA and 1-5 RepB is preferably used as the core repeat. More preferably, the tandem of 1-5 RepA is located near the N-terminal position of the entire fusion protein, and the tandem of 1-5 RepB is located at the C-terminal position of the entire fusion protein.
上述N末端非重复区域(N-NRT),氨基酸序列如SEQ ID NO:3所示,C末端非重复区域(C-NRT),氨基酸序列如SEQ ID NO:4所示。The amino acid sequence of the N-terminal non-repeating region (N-NRT) is shown in SEQ ID NO: 3, and the amino acid sequence of the C-terminal non-repeating region (C-NRT) is shown in SEQ ID NO: 4.
本申请中发明人将RepA以5个串联体的形式(RepA5)进行基因合成,同时也将RepB 以5个串联体的形式(RepB5)进行基因合成。另外为了便于后续的基因操作,编码RepA5及RepB5的核苷酸的5’端和3’端分别引入了同尾酶酶切位点BamHI和BglII。In the present application, the inventors performed gene synthesis in the form of five tandems (RepA5), and also performed gene synthesis in the form of five tandems (RepB5). In addition, in order to facilitate subsequent gene manipulation, the 5 ′ and 3 ′ ends of the nucleotides encoding RepA5 and RepB5 were introduced with homologous enzyme digestion sites BamHI and BglII, respectively.
本发明所涉及的部分序列如表1所示:The partial sequence involved in the present invention is shown in Table 1:
表1Table 1
Figure PCTCN2018094616-appb-000001
Figure PCTCN2018094616-appb-000001
所述核苷酸序列均经过针对大肠杆菌表达系统进行密码子优化,从而提高在大肠杆菌中的表达量。上述串联体核苷酸序列可由PCR的方法制备,也可由基因合成的方法制备。The nucleotide sequences are codon optimized for the E. coli expression system, thereby increasing the expression in E. coli. The tandem nucleotide sequence can be prepared by PCR or by gene synthesis.
本发明还提供了包含上述核苷酸序列的表达载体,该载体只要与大肠杆菌表达系统相匹配即可,优选具有拷贝数高、表达效率高的载体,如pET21b、pET28a、pBV220等。The present invention also provides an expression vector containing the above-mentioned nucleotide sequence, as long as the vector matches the E. coli expression system, preferably a vector with a high copy number and high expression efficiency, such as pET21b, pET28a, pBV220 and the like.
本发明还提供了包含上述表达载体的大肠杆菌菌株,优选BL21(DE3)、BL21(DE3)plys、Rosetta(DE3)、Transetta(DE3)等。The invention also provides an E. coli strain, preferably BL21 (DE3), BL21 (DE3) plys, Rosetta (DE3), Transetta (DE3), etc., comprising the expression vector described above.
本发明还提供了重组蜘蛛丝蛋白高密度发酵生产方法,具体包括:发酵种子活化、发酵一级种子液制备、发酵二级种子制备、高密度发酵,所述高密度发酵具体包括如下步骤:The invention also provides a method for producing high-density fermentation of recombinant spider silk protein, which specifically includes: activation of fermented seeds, preparation of fermented first-stage seed liquid, preparation of fermented second-stage seeds, and high-density fermentation. The high-density fermentation specifically includes the following steps:
将制备好的二级种子液按照5-15%的接种量接入到含分批发酵培养基的灭菌后的发酵罐中;Inserting the prepared secondary seed solution into a sterilized fermentation tank containing a batch fermentation medium according to an inoculation amount of 5-15%;
设定发酵温度为37℃、pH为6.8-7.2之间、DO设定在30-40%之间;Set the fermentation temperature to 37 ° C, pH to 6.8-7.2, and DO to 30-40%;
发酵开始后定期取样进行OD 600和菌体湿重的测定,待DO曲线出现急剧上升的时候表明分批培养基中葡萄糖耗尽,开始进行补料培养(补料培养基的流加速度维持在8-12g/L/h); After the start of fermentation, samples were taken periodically to determine the OD 600 and the wet weight of the bacteria. When the DO curve showed a sharp rise, it indicated that the glucose in the batch medium was depleted and the feed culture was started (the flow acceleration of the feed medium was maintained at 8). -12g / L / h);
待菌体生长至OD 600至40-60之间,使得发酵温度至20-37℃,待温度稳定后向发酵罐中加入终浓度为0.2-1.0mM的IPTG进行诱导表达;诱导表达8-12h结束培养。 After the bacteria grow to between OD 600 and 40-60, the fermentation temperature reaches 20-37 ° C. After the temperature is stabilized, add IPTG with a final concentration of 0.2-1.0mM to the fermentation tank to induce expression; induce expression 8-12h End cultivation.
所述分批发酵培养基成分包括:一水合柠檬酸0.5-3g/L,磷酸二氢钾8-15g/L,磷酸氢二铵3-7g/L,葡萄糖10-20g/L或者含有甘油15-30g/L,七水合硫酸镁1-3g/L。在发酵接种之前还要向分批发酵培养基中加入1/1000(V/V)的微量元素母液用于维持菌体正常生长和代谢。The components of the batch fermentation medium include: 0.5-3 g / L of citric acid monohydrate, 8-15 g / L of potassium dihydrogen phosphate, 3-7 g / L of diammonium hydrogen phosphate, 10-20 g / L of glucose or 15 containing glycerin -30g / L, magnesium sulfate heptahydrate 1-3g / L. Before fermentation inoculation, a 1/1000 (V / V) trace element mother liquor is added to the batch fermentation medium to maintain the normal growth and metabolism of the bacteria.
所述补料培养基主要成分包括:甘油1024g/L,七水合硫酸镁10-20g/L,酵母粉30-60g/L,在补料开始之前还要在补料培养基中加入1/1000(V/V)的微量元素母液用于维持菌体正常生长和代谢。The main components of the feed medium include: 1024g / L of glycerin, 10-20g / L of magnesium sulfate heptahydrate, and 30-60g / L of yeast powder. Before the start of feeding, 1/1000 must be added to the feed medium. (V / V) trace element mother liquor is used to maintain normal growth and metabolism of bacteria.
所述微量元素母液成分包括:FeSO 4.7H 2O 10g/L、ZnSO 4.7H 2O 2.25g/L、CuSO 4.5H 2O 15g/L、MnSO 4.5H 2O 5g/L、CaCl 2.7H 2O 1g/L、CoCl.6H 2O 1g/L、Na 2MoO 4.2H 2O 1.125g/L、H 3BO 30.0625g/L、HCl 41.75ml、Biotin 0.5g/L。 The components of the trace element mother liquid include: FeSO 4 .7H 2 O 10g / L, ZnSO 4 .7H 2 O 2.25g / L, CuSO 4 .5H 2 O 15g / L, MnSO 4 .5H 2 O 5g / L, CaCl 2 .7H 2 O 1g / L, CoCl.6H 2 O 1g / L, Na 2 MoO 4 .2H 2 O 1.125g / L, H 3 BO 3 0.0625g / L, HCl 41.75ml, Biotin 0.5g / L.
所述发酵种子活化方法具体为:将构建好的重组蜘蛛丝蛋白大肠杆菌菌株冻存管使用三区划线的方法接种到LB固体培养基中,37℃过夜培养进行活化。The method for activating the fermented seeds is specifically: inoculating the constructed recombinant spider silk protein E. coli strain cryopreservation tube into a LB solid medium using a three-zone streaking method, and incubating at 37 ° C overnight for activation.
所述发酵一级种子液制备方法具体为:从固体培养基上挑取形状饱满、大小适中的单菌落接种到LB液体培养基中,37℃,220rpm摇床培养8-10h,此为一级种子液。The method for preparing the first-stage fermented seed liquid is specifically: picking a single colony with a full shape and a moderate size from a solid medium and inoculating it into the LB liquid medium, and culturing at 37 ° C and 220 rpm for 8-10 hours in a shaker. Seed liquid.
所述发酵二级种子制备方法具体为:将一级种子液按照1%的接种量转接到新鲜的LB液体培养基中,37℃,220rpm摇床培养至OD 600≈3-5之间,此为二级种子液制备。 The method for preparing the fermented secondary seeds is specifically: transferring the primary seed liquid into a fresh LB liquid medium according to an inoculation amount of 1%, and culturing at 37 ° C and 220 rpm in a shaker to between OD 600 ≈3-5, This is a secondary seed liquid preparation.
上述任何用于菌体培养的器皿和培养基在使用前均应进行过滤或者湿热灭菌,所述任何培养基在灭菌结束冷却后使用前均应加入终浓度为50μg/ml的卡那霉素以保证纯种培养。Any of the above vessels and culture media used for bacterial culture should be filtered or humid-heat sterilized before use, and any culture medium should be added with kana mold at a final concentration of 50 μg / ml before use after cooling after sterilization. To ensure thoroughbred culture.
本发明还提供了重组蜘蛛丝蛋白纯化方法,包括如下步骤:The invention also provides a method for purifying recombinant spider silk protein, including the following steps:
1、取一定量的高密度发酵菌体使用bufferA(50mM Tris、100mM氯化钠、1mM EDTA,pH8.0)重悬至100g/L,将上述菌体悬浮液使用高压均质机进行菌体破碎。1. Take a certain amount of high-density fermentation bacteria and resuspend them to 100 g / L using buffer A (50 mM Tris, 100 mM sodium chloride, 1 mM EDTA, pH 8.0), and use the high-pressure homogenizer to perform the bacterial cells. broken.
2、将上述菌体裂解液使用低温离心机10000g离心30min,丢弃沉淀,收集上清。2. Centrifuge the above bacterial lysate using a low-temperature centrifuge at 10,000 g for 30 minutes, discard the precipitate, and collect the supernatant.
3、离心收集第2步中收集的菌体裂解物上清液,放入到预热到75℃的水浴条件下保温10-50min,保温处理过程中要不断的温和搅拌,该过程称之为菌体裂解物的热处理。3. Collect the supernatant of the bacterial lysate collected in step 2 by centrifugation, and put it in a water bath preheated to 75 ° C for 10-50min. The process of incubation should be continuously and gently stirred. This process is called Heat treatment of cell lysate.
4、将步骤3中热处理后的菌体裂解物离心收集,去除沉淀,收集上清液,上清液使用0.8μm水系膜进行过滤除去颗粒性杂质。4. Centrifugally collect the bacterial lysate after the heat treatment in step 3 to remove the precipitate, collect the supernatant, and filter the supernatant using a 0.8 μm aqueous membrane to remove particulate impurities.
5、IMAC亲和层析纯化即得目的蛋白。5. Purification by IMAC affinity chromatography can obtain the target protein.
本申请发明人根据己报道的蜘蛛丝蛋白的氨基酸序列,结合蜘蛛丝蛋白的模块结构特性和功能的关系,优化设计了一系列新型蜘蛛丝蛋白序列,它集高强度、高弹性等蜘蛛丝主要特性于一体。并且,通过基因工程技术将这些序列分别导入到大肠杆菌并建立相应的高密度发酵工艺成功实现了蛛丝蛋白的原核高效可溶表达。而以往为了实现蛛丝蛋白的工业化应用,所设计的蛛丝蛋白往往在保证性能的前提下更多的是为了制备量的考虑,但对于医疗制品等需要精纯产品的特定领域,以往设计的蛛丝蛋白却有着先天的不足,即使能获得精纯产品,也需要付出巨大的投入。鉴于此,发明人根据蜘蛛丝蛋白的性质设计出了一系列可以用原核系统可溶表达的蛛丝蛋白,经过精纯后重组蜘蛛丝蛋白纯度(电泳纯)可以达到95%左右,以该蛛丝蛋白系列经过静纺或湿纺工艺制备的蛛丝膜、蛛丝纤维就可以有2.5-6MPa、40-280MPa的力学强度,并且具有良好的细胞相容性和止血效果,这完全可以满足了医用领域的特殊要求,具有进一步开发的价值。The inventors of the present application optimized a series of new spider silk protein sequences based on the reported amino acid sequences of spider silk proteins and the relationship between the structural characteristics and function of the spider silk proteins. Features in one. In addition, these sequences were respectively introduced into E. coli by genetic engineering technology and the corresponding high-density fermentation process was established to successfully achieve efficient prokaryotic soluble expression of spider silk proteins. In the past, in order to achieve the industrial application of spider silk protein, the designed spider silk protein is often designed to consider the amount of preparation under the premise of ensuring performance. However, for specific areas that require pure products such as medical products, the past design Spider silk protein has innate shortcomings, and even if it can obtain pure products, it needs to pay a huge investment. In view of this, the inventors have designed a series of spider silk proteins that can be expressed soluble in the prokaryotic system according to the properties of the spider silk protein. After purification, the purity of the recombinant spider silk protein (electrophoretic purity) can reach about 95%. The silk protein series of arachnoid membrane and arachnid fiber prepared through the static spinning or wet spinning process can have a mechanical strength of 2.5-6MPa and 40-280MPa, and have good cell compatibility and hemostatic effect, which can be fully satisfied. The special requirements in the medical field have the value of further development.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1重组蜘蛛丝蛋白大肠杆菌菌株构建原理Figure 1 Construction principle of recombinant spider silk protein E. coli strain
图2不同设计方案的重组蜘蛛丝蛋白纯化后电泳图Figure 2 Electrophoresis diagrams of recombinant spider silk proteins after purification in different designs
图2-1 RepA5纯化样品电泳检测,其中M:蛋白分子量标准;lane1:RepA5纯化样品电泳;Figure 2-1 Electrophoretic detection of RepA5 purified sample, where M: protein molecular weight standard; lane1: RepA5 purified sample electrophoresis;
图2-2 RepA10纯化样品电泳检测,其中M:蛋白分子量标准;lane1-2:RepA10纯化样品电泳;Figure 2-2 Electrophoretic detection of RepA10 purified samples, where M: protein molecular weight standard; lane1-2: electrophoresis of RepA10 purified samples;
图2-3 RepA20纯化样品电泳检测,其中M:蛋白分子量标准;lane1:RepA20纯化样品电泳;Figure 2-3 Electrophoretic detection of RepA20 purified sample, where M: protein molecular weight standard; lane1: RepA20 purified sample electrophoresis;
图2-4 RepB5纯化样品电泳检测,其中M:蛋白分子量标准;lane1:RepB5纯化样品电泳;Figure 2-4 RepB5 purified sample electrophoresis detection, where M: protein molecular weight standard; lane1: RepB5 purified sample electrophoresis;
图2-5 RepB10纯化样品电泳检测,其中M:蛋白分子量标准;lane1:RepB10纯化样品电泳;Figure 2-5 Electrophoretic detection of RepB10 purified sample, where M: protein molecular weight standard; lane1: RepB10 purified sample electrophoresis;
图2-6 RepB15纯化样品电泳检测,其中M:蛋白分子量标准;lane1:RepB15纯化样品电泳;Figure 2-6 Electrophoretic detection of RepB15 purified sample, where M: protein molecular weight standard; lane1: RepB15 purified sample electrophoresis;
图2-7 RepA5RepB5纯化样品电泳检测,其中M:蛋白分子量标准;lane1:RepA5RepB5纯化样品电泳;Figure 2-7 Electrophoretic detection of RepA5RepB5 purified sample, where M: protein molecular weight standard; lane1: RepA5RepB5 purified sample electrophoresis;
图2-8 RepB5金属离子鳌合层析纯化样品电泳检测,其中M:蛋白分子量标准;lane1:层析纯化前;lane2:层析纯化穿透;lane3-4:层析纯化洗脱样品;Figure 2-8 Electrophoresis detection of RepB5 metal ion chelate chromatography purified sample, where M: protein molecular weight standard; lane1: before chromatography purification; lane2: chromatography purification penetration; lane3-4: chromatography purification elution sample;
图3重组蜘蛛丝蛋白静电纺丝样品扫描电镜图,其中上一:RepA5,上二:RepA10;上三:RepA20;中一:RepB5;中二:RepB10;中三:RepB15;下一:RepA5RepB5;下二:RepA5RepB5-RepA5RepB5Figure 3 Scanning electron microscopy image of the electrospinning sample of recombinant spider silk protein, where the first: RepA5, the second: RepA10; the third: RepA20; the first: RepB5; the second: RepB10; the third: RepB15; the next: RepA5RepB5; Next two: RepA5RepB5-RepA5RepB5
图4重组蜘蛛丝蛋白静电纺丝纤维膜力学测试结果,其中图4-1至图4-8依次对应的重组蜘蛛丝蛋白样品为:RepB5、RepB10、RepB15、RepA5、RepA10、RepA20、RepA5RepB5、RepA5RepB5-RepA5RepB5Figure 4 Mechanical test results of the electrospun fiber membrane of the recombinant spider silk protein, wherein the samples of the recombinant spider silk protein corresponding to Figure 4-1 to Figure 4-8 in this order are: RepB5, RepB10, RepB15, RepA5, RepA10, RepA20, RepA5RepB5, RepA5RepB5 -RepA5RepB5
图5重组蜘蛛丝蛋白湿法纺丝纤维丝力学性能测定,图5-1至图5-6分别为RepB5、RepB10、RepB15、RepA5、RepA10、RepA20湿法纺丝纤维丝的力学性能测定结果Figure 5 Mechanical properties of the wet-spun fiber of recombinant spider silk protein. Figures 5-1 to 5-6 show the results of the mechanical properties of the RepB5, RepB10, RepB15, RepA5, RepA10, and RepA20 wet-spun fibers.
图6重组蜘蛛丝蛋白湿法纺丝纤维丝电镜观测图,其中图6-1为RepA5湿法纺丝的电镜观察,图6-2为RepA5纤维丝拉断面观察Fig. 6 Electron microscopic observation of the wet-spun fiber of recombinant spider silk protein. Fig. 6-1 is an electron microscopy of the RepA5 wet-spinning. Fig. 6-2 is a cross-sectional observation of the RepA5 fiber.
图7小鼠成纤维细胞(L929)在重组蜘蛛丝蛋白静电纺丝纤维膜以及牛跟腱胶原蛋白(I型)膜上的贴附效果图,其中7-1为胶原蛋白膜,7-2为RepB5蛋白膜;Fig. 7 Attachment effect of mouse fibroblasts (L929) on recombinant spider silk protein electrospun fiber membrane and bovine Achilles tendon collagen (type I) membrane, where 7-1 is collagen membrane, 7-2 RepB5 protein membrane;
图8-1小鼠成纤维细胞(L929)在两种静电纺丝纤维膜上的增殖检测Figure 8-1 Proliferation of mouse fibroblasts (L929) on two types of electrospun fiber membranes
图8-2人脐带血间充质干细胞(MSC)在两种静电纺丝纤维膜上的增殖检测Figure 8-2 Proliferation detection of human umbilical cord blood mesenchymal stem cells (MSC) on two types of electrospun fiber membranes
图9-1 RepB5和牛跟腱胶原蛋白静电纺丝纤维膜的皮肤修复试验,第1天和第22天动物创面照片Fig. 9-1 Skin repair test of RepB5 and bovine Achilles tendon collagen electrospun fiber membranes, animal wound photos on day 1 and 22
图9-2 RepB5和牛跟腱胶原蛋白静电纺丝纤维膜的皮肤修复试验检测结果Figure 9-2 Skin repair test results of RepB5 and bovine Achilles tendon collagen electrospun fiber membrane
图10 RepB5和牛跟腱胶原蛋白体外凝血试验检测结果Figure 10 RepB5 and bovine Achilles tendon collagen in vitro coagulation test results
具体实施方式detailed description
以下实施例是针对本专利进行的进一步说明,需要说明的是实施例所述内容只是用于解释本专利并不构成对本专利发明内容的限制。The following examples are further descriptions of this patent. It should be noted that the content described in the examples is only used to explain this patent and does not constitute a limitation on the invention content of this patent.
实施例1重组蜘蛛丝蛋白大肠杆菌表达菌株构建Example 1 Construction of recombinant spider silk protein E. coli expression strain
本发明涉及到多个重组蜘蛛丝蛋白菌株的构建。重复模块的拼接(重复模块是指RepB5、RepA5)通过同尾酶的分子操作实现,方案流程如图1所示。下面以RepA5与RepB5串联体形成的杂交串联体(RepA5RepB5)为例进行说明,具体如下:The invention relates to the construction of multiple recombinant spider silk protein strains. The splicing of repeat modules (repeat modules refer to RepB5 and RepA5) is achieved by molecular manipulation of isotail enzymes. The scheme flow is shown in Figure 1. The following describes the hybrid tandem (RepA5RepB5) formed by the tandem of RepA5 and RepB5 as an example, as follows:
1、参考GenBank中已经公布的Argiopetrifasciata MaSp2拖丝蛋白mRNA序列(GenBank基因登录号为:AH015065.2),从中截取核心重复区域获得RepA和RepB核苷酸序列,通过 人工拼装和密码子优化后形成RepA5和RepB5核苷酸序列,分别如SEQ ID NO:5和SEQ ID NO:6所示。为了方便后续的分子操作,在不改变RepA5和RepB5的氨基酸序列条件下,在合成的RepA5和RepB5人工核苷酸序列的5’端和3’端非别引入了酶切位点BamHI和BglII。RepA5和RepB5人工核苷酸序列被分别克隆至pUC57质粒,形成重组质粒pUC57-RepA5和pUC57-RepB5。1. Refer to the already published Argiopetrifasciata MaSp2 mRNA protein sequence in GenBank (GenBank gene accession number: AH015065.2), cut out the core repeat region from it to obtain the RepA and RepB nucleotide sequences, and form them after artificial assembly and codon optimization. The nucleotide sequences of RepA5 and RepB5 are shown in SEQ ID NO: 5 and SEQ ID NO: 6, respectively. In order to facilitate the subsequent molecular manipulation, without changing the amino acid sequence of RepA5 and RepB5, the restriction sites BamHI and BglII were introduced at the 5 'and 3' ends of the synthetic RepA5 and RepB5 artificial nucleotide sequences. RepA5 and RepB5 artificial nucleotide sequences were cloned into pUC57 plasmid, respectively, to form recombinant plasmids pUC57-RepA5 and pUC57-RepB5.
2、将N-NRT与C-NRT基因序列(如SEQ ID NO:16和如SEQ ID NO:17所示)人工合成,其中N-NRT的5’端含有XbaI酶切位点,3’端含有BamHI酶切位点(该酶切位点作为N-NRT重组核苷酸的一部分,不改变N-NRT的氨基酸序列);C-NRT的5’端含有BglII酶切位点(该酶切位点作为N-NRT重组核苷酸的一部分,不改变N-NRT的氨基酸序列),3’端含有XhoI酶切位点;N-NRT与C-NRT对应的核苷酸以融合的形式合成,即N-NRT-C-NRT(5’→3’)。N-NRT-C-NRT通过酶切、酶连的方式插入pET28aplus载体(将pET28a原始载体去除原有BglII改造而成),记为pET28aplus-N-NRT-C-NRT。2. Synthesize the N-NRT and C-NRT gene sequences (such as SEQ ID NO: 16 and SEQ ID NO: 17), where the 5 'end of N-NRT contains the XbaI digestion site and the 3' end Contains BamHI digestion site (this digestion site is part of the N-NRT recombination nucleotide, does not change the amino acid sequence of N-NRT); C-NRT 5 'end contains BglII digestion site (the digestion As a part of the N-NRT recombination nucleotide, it does not change the amino acid sequence of N-NRT), the 3 'end contains XhoI digestion site; the nucleotide corresponding to N-NRT and C-NRT is synthesized in a fusion form , Which is N-NRT-C-NRT (5 '→ 3'). N-NRT-C-NRT was inserted into pET28aplus vector (recombined by removing the original BglII from pET28a original vector) by enzyme digestion and enzymatic ligation, and recorded as pET28aplus-N-NRT-C-NRT.
4、pUC57-RepA5和pUC57-RepB5使用BamHI和BglII酶切获取带有相应粘性末端的RepA5和RepB5片段。将pET28aplus-N-NRT-C-NRT使用BamHI和BglII酶切获取带有相应粘性末端的载体骨架片段。将酶切获取的粘性片段酶连后转化到大肠杆菌Transetta(DE3)中形成重组表达菌株。4. pUC57-RepA5 and pUC57-RepB5 were digested with BamHI and BglII to obtain RepA5 and RepB5 fragments with corresponding sticky ends. PET28aplus-N-NRT-C-NRT was digested with BamHI and BglII to obtain a vector backbone fragment with corresponding sticky ends. The viscous fragment obtained by enzymatic digestion was ligated and transformed into E. coli Transetta (DE3) to form a recombinant expression strain.
5、从步骤4中的转化平板中挑取单克隆进行培养,提取质粒后使用BamHI和BglII酶切进行鉴定,根据同尾酶的切割原理分析鉴定获得的阳性克隆,阳性克隆即为Transetta(DE3)-RepA5和Transetta(DE3)-RepB5,对应的阳性质粒为pET28aplus-N-NRT-RepA5-C-NRT和pET28aplus-N-NRT-RepB5-C-NRT。5. Pick a single clone from the transformation plate in step 4 for culture, extract the plasmid and use BamHI and BglII to digest and identify, and analyze and identify the positive clones obtained according to the principle of cleavage of the same tail. The positive clones are Transetta (DE3). ) -RepA5 and Transetta (DE3) -RepB5. The corresponding positive plasmids are pET28aplus-N-NRT-RepA5-C-NRT and pET28aplus-N-NRT-RepB5-C-NRT.
6、pET28aplus-N-NRT-RepA5-C-NRT使用BglII酶切获取带有相应粘性末端的载体骨架片段,pUC57-RepA5使用BamHI和BglII酶切获取带有相应粘性末端的RepA5片段。将2种粘性片段连后转化到大肠杆菌Transetta(DE3)中形成重组表达菌株,鉴定后得到Transetta(DE3)-RepA10(含有10个RepA的串联体),对应的阳性质粒为pET28aplus-N-NRT-RepA10-C-NRT。同理,对pET28aplus-N-NRT-RepA10-C-NRT进行重复操作即可获得含有n个RepA5的串联体(如含有5、10、20、30…个RepA的串联体)重组大肠杆菌菌株,即为Transetta(DE3)-n×RepA5。6. pET28aplus-N-NRT-RepA5-C-NRT was digested with BglII to obtain a vector backbone fragment with corresponding sticky ends, and pUC57-RepA5 was digested with BamHI and BglII to obtain a RepA5 fragment with corresponding sticky ends. The two cohesive fragments were ligated and transformed into E. coli Transetta (DE3) to form a recombinant expression strain. After identification, Transetta (DE3) -RepA10 (a tandem containing 10 RepA) was obtained. The corresponding positive plasmid was pET28aplus-N-NRT. -RepA10-C-NRT. Similarly, pET28aplus-N-NRT-RepA10-C-NRT can be repeatedly operated to obtain a tandem containing n RepA5 (such as a tandem containing 5, 10, 20, 30 ... RepA) recombinant E. coli strain, That is Transetta (DE3) -n × RepA5.
7、同理,将pUC57-RepB5和pET28aplus-N-NRT-RepB5-C-NRT分别按照步骤4-6中的操作,即可获得Transetta(DE3)-n×RepB5(含有n个RepB5的串联体)。7. In the same way, transpose pUC57-RepB5 and pET28aplus-N-NRT-RepB5-C-NRT according to steps 4-6, respectively, to obtain Transetta (DE3) -n × RepB5 (a tandem body containing n RepB5 ).
8、将pET28aplus-N-NRT-RepA5-C-NRT质粒使用BglII酶切获取带有相应粘性末端的载体骨架片段,将pET28aplus-N-NRT-RepB5-C-NRT使用BamHI和BglII酶切获取带有相应粘性末 端的RepB5片段。将带有粘性末端的RepB5与带有粘性末端的pET28aplus-N-NRT-RepA5-C-NRT酶连后转化到大肠杆菌Transetta(DE3)中形成重组表达菌株。从转化平板中挑取单克隆进行培养,提取质粒后使用BamHI和BglII酶切进行鉴定,根据同尾酶的切割原理分析鉴定获得的阳性克隆,阳性克隆即为Transetta(DE3)-RepA5RepB5,对应的阳性质粒为pET28aplus-N-NRT-RepA5-RepB5-C-NRT。8. Digest pET28aplus-N-NRT-RepA5-C-NRT plasmid with BglII to obtain the vector backbone fragment with the corresponding sticky ends, pET28aplus-N-NRT-RepB5-C-NRT to digest the band with BamHI and BglII RepB5 fragment with corresponding sticky ends. RepB5 with a sticky end was linked to pET28aplus-N-NRT-RepA5-C-NRT with a sticky end and transformed into E. coli Transetta (DE3) to form a recombinant expression strain. A single clone was selected from the transformation plate and cultured. The plasmid was extracted and identified by digestion with BamHI and BglII. The positive clone obtained was analyzed and identified according to the principle of cleavage of the same tail enzyme. The positive clone was Transetta (DE3) -RepA5RepB5. The positive plasmid was pET28aplus-N-NRT-RepA5-RepB5-C-NRT.
9、将上述酶切鉴定为阳性的菌株测序验证序列是否正确。9. Sequencing the strains identified as positive by the above enzyme digestion to verify whether the sequences are correct.
实施例2重组蜘蛛丝蛋白大肠杆菌菌株高密度发酵Example 2 High-density fermentation of recombinant spider silk protein E. coli strains
蜘蛛丝蛋白含有大量的重复氨基酸序列,这一特性导致其在大肠杆菌中重组表达时会遇到tRNA池枯竭、基因复制障碍、蛋白翻译截断等问题,最终导致表达量不高。有研究表明,随着人工蛛丝蛋白的分子量增大(大于60KDa),蛋白的表达难度会极大上升,并且可能出现表达失败的问题。而天然蛛丝蛋白的分子量可以达到200KDa以上,虽然没有直接研究表明蛛丝蛋白的分子量和其力学性能呈正比例关系,但仍需要使人工设计的蛛丝蛋白在分子量上与天然蛛丝蛋白尽可能相近。所以,重组蜘蛛丝蛋白就要在分子量和大肠杆菌表达量上做好平衡,分子量过大则表达量降低或者表达失败,分子量过小则对天然序列的仿生程度低。Spider silk protein contains a large number of repetitive amino acid sequences. This characteristic causes it to encounter problems such as depletion of the tRNA pool, obstacles to gene replication, truncation of protein translation, etc., resulting in low expression levels. Studies have shown that as the molecular weight of artificial spider silk protein increases (greater than 60KDa), the expression of the protein will increase greatly, and the problem of expression failure may occur. The molecular weight of natural spider silk protein can reach more than 200KDa. Although there is no direct research showing that the molecular weight of spider silk protein is directly proportional to its mechanical properties, it is still necessary to make the artificially designed spider silk protein as close as possible to the natural spider silk protein in molecular weight. similar. Therefore, the recombinant spider silk protein must balance molecular weight with the expression of E. coli. If the molecular weight is too large, the expression will be reduced or the expression will fail. If the molecular weight is too small, the biomimetic degree of the natural sequence will be low.
本部分阐述了发明人关于重组蜘蛛丝蛋白的高密度发酵工艺,以Transetta(DE3)-RepA20的发酵工艺进行说明(RepA20分子量在实施例1中的蛛丝蛋白构建体中分子量较大,达到88KDa,对于工艺产量的评价具有一定代表性)。This section describes the inventor's high-density fermentation process for recombinant spider silk protein, which is illustrated by the fermentation process of Transetta (DE3) -RepA20 (The molecular weight of RepA20 in the spider silk protein construct in Example 1 is relatively large, reaching 88 KDa The evaluation of process yield is representative.
1、将构建好的重组重组蜘蛛丝蛋白大肠杆菌菌株冻存管使用三区划线的方法接种到LB固体培养基中,37℃,220rpm摇床过夜培养进行活化;1. Inoculate the constructed recombinant recombinant spider silk protein E. coli strain cryopreservation tube into the LB solid medium using a three-zone streaking method, and incubate at 37 ° C, 220 rpm with a shaker overnight for activation;
2、从固体培养基上挑取形状饱满、大小适中的单菌落接种到LB液体培养基中,37℃,220rpm摇床培养8-10h,此为一级种子液。2. Pick a single colony with a full shape and a moderate size from the solid medium and inoculate it into the LB liquid medium. Incubate at 37 ° C and 220 rpm for 8-10 hours. This is the first-level seed solution.
3、将一级种子液按照1%的接种量转接到新鲜的LB液体培养基中,37℃,220rpm摇床培养至OD 600≈3-5之间,此为二级种子液制备。 3. Transfer the primary seed solution to fresh LB liquid medium at 1% inoculum, and culture at 37 ° C and 220 rpm in a shaker until OD 600 ≈3-5. This is the secondary seed solution preparation.
4、将制备好的二级种子液接种到发酵培养基中开始补料-分批高密度发酵培养,该高密度发酵工艺可以实现重组蜘蛛丝蛋白的大量表达。所述分批发酵培养基成分包括:一水合柠檬酸1.7g/L,磷酸二氢钾12g/L,磷酸氢二铵4g/L,甘油30g/L,七水合硫酸镁1.2g/L,在发酵接种之前还要向分批发酵培养基中加入1/1000(V/V)的微量元素母液用于维持菌体正常生长和代谢,所述微量元素母液成分包括:FeSO 4.7H 2O 10g/L、ZnSO 4.7H 2O 2.25g/L、CuSO 4.5H 2O 15g/L、MnSO 4.5H 2O 5g/L、CaCl 2.7H 2O 1g/L、CoCl.6H 2O 1g/L、Na 2MoO 4.2H 2O 1.125g/L、H 3BO 3 0.0625g/L、HCl 41.75ml、Biotin 0.5g/L。所述补料培养基主要成分包括:甘油1024g/L,七水合硫酸镁20g/L,酵母粉50g/L。在补料开始之前还要补料培养基中加入1/1000(V/V)的上述微量元素母液用于维持菌体正常生长和代谢。所述的高密度发酵方法步骤包括:将制备好的二级种子液按照5-15%的接种量接入到灭菌后的发酵罐中→设定发酵温度为37℃、pH为6.8-7.0之间、DO设定在30-40%之间(通过转速/空气/高纯氧的关联进行控制)→发酵开始后定期取样进行OD 600和菌体湿重的测定,待DO曲线出现急剧上升的时候表明分批培养基中葡萄糖耗尽,开始进行补料培养(补料培养基的流加速度维持在12g/L/h(补料培养基质量/发酵液初始体积/时间))→待菌体生长至0D 600≈40-55之间,降低发酵温度至30℃,待温度稳定后向发酵罐中加入终浓度为0.5的IPTG进行诱导表达→诱导表达6h结束培养。 4. The prepared secondary seed liquid is inoculated into the fermentation medium to start feeding-batch high-density fermentation culture. The high-density fermentation process can realize the large-scale expression of recombinant spider silk protein. The components of the batch fermentation medium include: 1.7 g / L of citric acid monohydrate, 12 g / L of potassium dihydrogen phosphate, 4 g / L of diammonium hydrogen phosphate, 30 g / L of glycerin, 1.2 g / L of magnesium sulfate heptahydrate, Before fermentation inoculation, a 1/1000 (V / V) trace element mother liquor is added to the batch fermentation medium to maintain the normal growth and metabolism of the bacteria. The trace element mother liquor components include: FeSO 4 .7H 2 O 10g / L, ZnSO 4 .7H 2 O 2.25g / L, CuSO 4 .5H 2 O 15g / L, MnSO 4 .5H 2 O 5g / L, CaCl 2 .7H 2 O 1g / L, CoCl.6H 2 O 1g / L, Na 2 MoO 4 .2H 2 O 1.125 g / L, H 3 BO 3 0.0625 g / L, HCl 41.75 ml, Biotin 0.5 g / L. The main components of the feed medium include: 1024 g / L of glycerin, 20 g / L of magnesium sulfate heptahydrate, and 50 g / L of yeast powder. Before the start of the feeding, the above-mentioned trace element mother liquor of 1/1000 (V / V) is added to the feeding medium to maintain the normal growth and metabolism of the bacteria. The steps of the high-density fermentation method include: inserting the prepared secondary seed liquid into a sterilized fermentation tank according to an inoculation amount of 5-15% → setting the fermentation temperature to 37 ° C and the pH to 6.8-7.0 The DO is set between 30-40% (controlled by the speed / air / high-purity oxygen correlation) → regular sampling after the start of fermentation to measure OD 600 and the wet weight of the bacteria, until the DO curve shows a sharp rise It indicates that the glucose in the batch medium is depleted, and the feed culture is started (the flow acceleration of the feed medium is maintained at 12 g / L / h (feed medium quality / fermentation liquid initial volume / time)) → wait for bacteria When the body grows to between 0D 600 ≈ 40-55, reduce the fermentation temperature to 30 ° C. After the temperature is stabilized, add IPTG with a final concentration of 0.5 to the fermentor to induce expression → induce the expression and end the culture 6h.
上述任何用于菌体培养的器皿和培养基在使用前均应进行过滤或者湿热灭菌,所述任何培养基在灭菌结束冷却后使用前均应加入终浓度为50μg/ml的卡那霉素以保证纯种培养。重组蜘蛛丝蛋白含有大量的氨基酸重复序列,实施例1获得的菌株采用该高密度发酵工艺可实现有效表达,部分菌株可以达到0.5g/L以上,为重组蜘蛛丝的大规模应用奠定了基础。Any of the above vessels and culture media used for bacterial culture should be filtered or humid-heat sterilized before use, and any culture medium should be added with kana mold at a final concentration of 50 μg / ml before use after cooling after sterilization. To ensure thoroughbred culture. The recombinant spider silk protein contains a large number of amino acid repeats. The strain obtained in Example 1 can achieve effective expression using this high-density fermentation process, and some strains can reach more than 0.5 g / L, which lays the foundation for the large-scale application of recombinant spider silk.
实施例3重组蜘蛛丝蛋白纯化制备Example 3 Purification and Preparation of Recombinant Spider Silk Protein
此部分内容,阐述了蜘蛛丝蛋白的非层析的蛋白纯化手段,经过简单纯化后重组蜘蛛丝蛋白纯度(电泳纯)即可以达到75%以上,需要明确的是,其残余的杂质对于后续的纺丝等操作无明显影响,该纯度蛛丝蛋白已能满足绝大部分的工业化应用。而由于本发明中的人工蛛丝蛋白在N端含有6×His标签,并且所设计分子为可溶表达,因此使得本专利中的人工蛛丝蛋白通过IMAC亲和层析的方法纯化更可以获得95%以上的电泳纯度,达到了精制纯化的要求,完全可以满足医疗等特殊用途需要。本实施例使用实施例2制备的发酵菌体分别采用简易纯化与精制纯化两种工艺处理,具体纯化操作如下:This section describes the non-chromatographic protein purification method of spider silk protein. After simple purification, the purity of the recombinant spider silk protein (electrophoretic purity) can reach more than 75%. It needs to be clear that its residual impurities are important for subsequent Spinning and other operations have no obvious impact, and the pure spider silk protein can meet most industrial applications. Because the artificial spider silk protein in the present invention contains a 6 × His tag at the N-terminus, and the designed molecule is soluble, the artificial spider silk protein in this patent can be more purified by IMAC affinity chromatography. The electrophoretic purity is above 95%, which meets the requirements of refining and purification, and can completely meet the needs of special applications such as medical treatment. In this embodiment, the fermented bacterial cells prepared in Example 2 are respectively processed by simple purification and refining purification processes, and the specific purification operations are as follows:
1、取一定量的高密度发酵菌体使用bufferA(50mM Tris、100mM氯化钠、1mM EDTA,pH8.0)重悬至100g/L,将上述菌体悬浮液使用高压均质机进行菌体破碎。1. Take a certain amount of high-density fermentation bacteria and resuspend them to 100 g / L using buffer A (50 mM Tris, 100 mM sodium chloride, 1 mM EDTA, pH 8.0), and use the high-pressure homogenizer to perform the bacterial cells. broken.
2、将上述菌体裂解液使用低温离心机10000g离心30min,丢弃沉淀,收集上清。2. Centrifuge the above bacterial lysate using a low-temperature centrifuge at 10,000 g for 30 minutes, discard the precipitate, and collect the supernatant.
3、离心收集第2步中收集的菌体裂解物上清液,放入到预热到75℃的水浴条件下保温20min,保温处理过程中要不断的温和搅拌,该过程称之为菌体裂解物的热处理。3. Collect the supernatant of the bacterial lysate collected in step 2 by centrifugation, and place it in a water bath preheated to 75 ° C for 20 minutes. During the heat preservation process, continuous gentle stirring is required. This process is called bacterial cells. Thermal treatment of lysate.
4、将步骤3中热处理后的菌体裂解物离心收集,去除沉淀,收集上清液,上清液使用0.8μm水系膜进行过滤除去颗粒性杂质。4. Centrifugally collect the bacterial lysate after the heat treatment in step 3 to remove the precipitate, collect the supernatant, and filter the supernatant using a 0.8 μm aqueous membrane to remove particulate impurities.
5、将第4步中过滤处理后的上清液加入3M硫酸铵水溶液进行盐析,硫酸铵加入时要缓 慢,并且盐析体系处于快速搅拌混合的状态。随着硫酸铵的加入,待盐析体系出现浑浊时,停止加入硫酸铵,将盐析体系放于4℃搅拌放置5h。5. Add the supernatant after the filtration treatment in step 4 to a 3M aqueous ammonium sulfate solution for salting out. Add ammonium sulfate slowly, and the salting-out system is in a state of rapid stirring and mixing. With the addition of ammonium sulfate, when the salting-out system appears turbid, stop adding ammonium sulfate, and place the salting-out system at 4 ° C with stirring for 5 h.
6、将第5步中的盐析体系离心处理,收集盐析沉淀,沉淀中即含有人工蛛丝蛋白。6. Centrifuge the salting-out system in step 5 to collect the salting-out precipitate. The precipitate contains artificial spider silk protein.
7、将步骤6中的人工蛛丝蛋白盐析沉淀使用20-50%的乙醇水溶液反复的洗涤,直至硫酸铵被基本去除(洗涤液的电导率不高于0.05mS/cm),此时收集蛛丝蛋白沉淀,将该蛋白冻干后即获得蛛丝蛋白原料。7. The artificial spider silk protein salted-out precipitate in step 6 is repeatedly washed with a 20-50% ethanol aqueous solution until the ammonium sulfate is substantially removed (the conductivity of the washing solution is not higher than 0.05 mS / cm), and then collected The spider silk protein is precipitated, and the spider silk protein raw material is obtained after lyophilizing the protein.
取部分沉淀蛋白使用实施例1中的方法进行SDS-PAGE分析,分析结果如图2所示,电泳检测结果使用灰度分析各种人工蛛丝蛋白均可以获得75%以上电泳纯度。最终离心收集得到的蛋白可用冷冻干燥、热风干燥、喷雾干燥等方法进行干燥处理即可得到纯化后的蜘蛛丝蛋白,干燥后的蛛丝蛋白称重后,根据纯度和发酵体积核算重组蜘蛛丝蛋白RepA20的发酵产量为0.45g/L。A part of the precipitated protein was taken for SDS-PAGE analysis using the method in Example 1. The analysis result is shown in FIG. 2. The electrophoresis detection results were obtained by using gray scale analysis of various artificial spider silk proteins to obtain electrophoretic purity of more than 75%. The final protein collected by centrifugation can be dried by freeze drying, hot air drying, spray drying and other methods to obtain purified spider silk protein. After drying, the spider silk protein is weighed, and the recombinant spider silk protein is calculated based on the purity and fermentation volume. The fermentation yield of RepA20 was 0.45 g / L.
同时,发明人还选择RepB5进行了IMAC亲和层析纯化的研究,亲和层析使用本实施例步骤4中加热后的样品作为起始待纯化样品(样品中EDTA应被去除),纯化方法参考Gehealthcare的镍离子鳌合层析填料的纯化方案开展,纯化后样品电泳分析如图2-8所示。分析可知,目标蛋白可以有效地与层析填料结合,并且经过纯化可以获得95%以上的电泳纯度,达到了精制纯化的要求。At the same time, the inventor also selected RepB5 for the purification research of IMAC affinity chromatography. The affinity chromatography uses the sample heated in step 4 of this example as the initial sample to be purified (EDTA should be removed from the sample). Purification method Refer to Gehealthcare's purification scheme for nickel ion chelate chromatography. The electrophoretic analysis of the purified sample is shown in Figure 2-8. According to the analysis, the target protein can be effectively combined with the chromatographic packing, and the electrophoretic purity can be more than 95% after purification, which meets the requirements of purification.
申请人采用实施例2、实施例3的制备发酵、纯化工艺分别对部分构建的重组蜘蛛丝蛋白大肠杆菌菌株进行发酵和纯化制备,通过结果核算,不同重组蜘蛛丝蛋白菌株蛋白表达量如表2所示。The applicant used the fermentation and purification processes of Example 2 and Example 3 to ferment and purify the partially constructed recombinant spider silk protein E. coli strain, respectively. Based on the results calculation, the protein expression levels of different recombinant spider silk protein strains are shown in Table 2 As shown.
表2Table 2
Figure PCTCN2018094616-appb-000002
Figure PCTCN2018094616-appb-000002
实施例4重组蜘蛛丝蛋白静电纺丝原液制备和静电纺丝Example 4 Preparation of Electrospinning Dope of Recombinant Spider Silk Protein and Electrospinning
1、取干燥后的重组蜘蛛丝蛋白样品使用HFIP(六氟异丙醇)进行溶解,投料量为10%(wt%),室温搅拌溶解48h以上,至溶液均匀透亮。1. Take the dried recombinant spider silk protein sample and use HFIP (hexafluoroisopropanol) to dissolve it. The feeding amount is 10% (wt%). Stir and dissolve at room temperature for more than 48h until the solution is uniform and transparent.
2、取上述纺丝原液2ml加入到注射器中,选择注射针为27G针头,设定注射速率为1ml/h,设定电压为16KV,设定接收距离为15cm,纺丝头左右摆幅宽度为8-12cm,接受基板为锡箔纸,进行静电纺丝制备纤维膜。2. Take 2ml of the spinning dope and add it to the syringe. Select the 27G needle as the injection needle, set the injection rate to 1ml / h, set the voltage to 16KV, set the receiving distance to 15cm, and the width of the spinning head to the left and right. 8-12cm, the receiving substrate is tin foil, and the fiber membrane is prepared by electrostatic spinning.
3、将上述静电纺丝制备的纤维膜,使用扫描电镜进行检测分析,分析结果如图3所示。3. The fiber membrane prepared by the above-mentioned electrospinning was detected and analyzed using a scanning electron microscope, and the analysis result is shown in FIG. 3.
4、将步骤2中制备的纤维膜使用裁刀裁剪(去除纺丝辐射的边缘部位)成宽度为1cm的条状。4. The fiber membrane prepared in step 2 is cut with a cutter (to remove the edge part of the spinning radiation) into a strip shape with a width of 1 cm.
5、将步骤4中制备的纤维膜从锡箔纸上剥离,将纤维膜使用数字式螺旋测微仪测定厚度,然后使用岛津制万能拉力试验机进行拉力测试(使用50N传感器,测试速度为10mm/min,相对湿度为40%,测试距离为2cm,预加载为0.1N),测试结果如图4所示。由图3、4可见,采用本专利的蜘蛛丝蛋白可满足静电纺丝对蛋白的可纺性要求,宏观上纤维膜均匀完整,扫描电镜显示微观上具有典型的纤维形貌,同时力学测定结果显示静电纺丝制备的重组蜘蛛丝蛋白纤维膜力学强度在2.5-6MPa之间。5. Peel the fiber film prepared in step 4 from the foil, use a digital spiral micrometer to measure the thickness of the fiber film, and then use a Shimadzu universal tensile tester to perform a tensile test (using a 50N sensor with a test speed of 10mm) / min, relative humidity is 40%, test distance is 2cm, preload is 0.1N), test results are shown in Figure 4. It can be seen from Figures 3 and 4 that the use of the spider silk protein of this patent can meet the requirements for the spinnability of the protein by electrospinning, and the fiber membrane is uniform and complete in the macro. Scanning electron microscopy shows a typical fiber morphology in the micro. It is shown that the mechanical strength of the recombinant spider silk protein fiber membrane prepared by electrostatic spinning is between 2.5-6MPa.
6、目前可以用于医用的人工皮肤要求材料的强度应在2-17MPa之间,因此所述静电纺丝获得的纤维膜在力学强度上具有皮肤类医用材料的应用潜力。6. At present, artificial skin that can be used for medical treatment requires that the strength of the material should be between 2-17 MPa. Therefore, the fiber membrane obtained by the electrospinning has mechanical application strength of skin-like medical materials.
实施例5重组蜘蛛丝蛋白湿法纺丝原液制备和湿法纺丝Example 5 Preparation of wet spinning solution of recombinant spider silk protein and wet spinning
1、取干燥后的蛋白样品使用HFIP(六氟异丙醇)溶剂进行溶解,蛋白浓度为20%(w/v%),室温搅拌溶解10h以上至溶液均匀透亮。1. Take the dried protein sample and dissolve it with HFIP (hexafluoroisopropanol) solvent. The protein concentration is 20% (w / v%). Stir and dissolve at room temperature for more than 10h until the solution is uniform and transparent.
2、将步骤1中的纺丝液去除泡沫,然后注入1ml注射器,使用27G注射针头从注射器中推出,纺丝液从针头中挤出后浸入到乙醇中被固化形成纤维丝。2. Remove the foam from the spinning solution in step 1, and then inject it into a 1ml syringe. Use a 27G injection needle to push it out of the syringe. The spinning solution is squeezed out of the needle and dipped in ethanol to be solidified to form fiber filaments.
3、将步骤2中的固化纤维丝取出,在80℃蒸汽中拉伸3-5倍,然后在150℃环境中暴露30s,获得成熟纤维丝。3. Take out the solidified fiber filament in step 2 and stretch it for 3-5 times in 80 ° C steam, and then expose it to 150 ° C for 30s to obtain mature fiber filament.
4、将步骤3中的成熟纤维丝使用岛津制万能拉力试验机进行拉力测试(使用50N传感器,测试速度为10mm/min,相对湿度为40%,测试距离为2cm,预加载为0.1N),测试结果如图5所示,力学强度在220~280Mpa之间。4. Use the Shimadzu universal tensile tester for tensile testing of the mature fiber yarn in step 3 (using a 50N sensor, a test speed of 10mm / min, a relative humidity of 40%, a test distance of 2cm, and a preload of 0.1N) The test results are shown in Figure 5. The mechanical strength is between 220 and 280Mpa.
5、将步骤3中的成熟纤维丝和步骤4中力学测定中拉断的纤维丝在扫描电镜下观察纤维表面和断面,结果如图6所示。5. Observe the surface and section of the fiber under the scanning electron microscope with the mature fiber in step 3 and the fiber broken in the mechanical measurement in step 4, and the results are shown in FIG. 6.
6、所述方法制备的纤维丝为较为规则的圆柱形,表面光滑为明显的沟槽,并且拉断面比较密实。相比较于目前报道的人工重组蜘蛛丝纤维丝的力学强度(40-280MPa),本发明人设计的几种重组蜘蛛丝蛋白对应的纤维丝力学强度属于较高水平。6. The fiber filament prepared by the method has a relatively regular cylindrical shape, the surface is smooth with obvious grooves, and the tensile fracture surface is relatively dense. Compared with the mechanical strength (40-280 MPa) of artificial recombinant spider silk fiber filaments reported at present, the mechanical strength of the fiber filaments corresponding to several recombinant spider silk proteins designed by the inventors belongs to a higher level.
实施例6重组蜘蛛丝蛋白静电纺丝膜细胞相容性评价Example 6 Compatibility Evaluation of Electrospinning Membrane of Recombinant Spider Silk Protein
本发明人静电纺丝法制备的重组蜘蛛丝蛋白纤维膜在物理形貌上具备静电纺丝纤维膜的特点,因此为了评价该纤维膜的生物学相容性,我们使用了人脐带血间充质干细胞(MSC)以及小鼠成纤维细胞(L929)的贴附和增值来进行评价。同时业内公认,天然的胶原蛋白具备优秀的生物相容性、利于皮肤修复和促凝血作用,体现在促进细胞的贴附、增值等特点上,因此我们在实验中采用了牛跟腱胶原蛋白制备的静电纺丝膜来进行比较。牛跟腱胶原蛋白静电纺丝膜制备参考实施例5中的方法,并在该方法的基础上调整了蛋白溶解的溶剂选择,所制备的两种蛋白静电纺丝膜在厚度上保证一致。具体的细胞相容性评价方法如下:The recombinant spider silk protein fiber membrane prepared by the inventor's electrospinning method has the characteristics of an electrospun fiber membrane in physical appearance. Therefore, in order to evaluate the biological compatibility of the fiber membrane, we used human umbilical cord blood mesenchyme Adhesion and appreciation of MSCs and mouse fibroblasts (L929) were evaluated. At the same time, it is recognized in the industry that natural collagen has excellent biocompatibility, is beneficial to skin repair and coagulation, and is reflected in the characteristics of promoting cell attachment and value-added. Therefore, we used bovine Achilles tendon collagen in the experiments. Comparison of electrospun membranes. For the preparation of bovine Achilles tendon collagen electrostatic spinning membrane, refer to the method in Example 5, and based on this method, the choice of solvent for protein dissolution is adjusted. The thickness of the prepared two kinds of protein electrostatic spinning membranes is consistent. Specific cytocompatibility evaluation methods are as follows:
1、取刚纺制完成的牛跟腱胶原蛋白和重组蜘蛛丝蛋白RepB5静电纺丝初生膜抽真空12h去除纤维膜内未挥发干净的溶剂,前者使用化学交联法进行交联固定,后者使用物理法固定,固定的目的是降低两种蛋白的水溶性。1. Take the freshly prepared bovine Achilles tendon collagen and the recombinant spider silk protein RepB5 primary membrane for vacuum spinning for 12h to remove the non-volatile clean solvent in the fiber membrane. The former is crosslinked and fixed by chemical crosslinking method, and the latter Physical fixation is used to reduce the water solubility of the two proteins.
2、将步骤1中固定完毕的纤维膜按照细胞培养皿孔的直径大小,裁切成合适的大小,保证纤维膜可以均匀、完全的覆盖培养皿底部。2. The fiber membrane fixed in step 1 is cut into a suitable size according to the diameter of the cell culture dish hole to ensure that the fiber membrane can evenly and completely cover the bottom of the culture dish.
3、将步骤2裁切完成的两种蛋白的圆形纤维膜分别使用75%乙醇浸泡2h后,取出分别铺于24孔板底部,晾干。胶原蛋白膜分别铺2块板,每块板6个孔,重组蛛丝蛋白RepB5膜分别铺2块板,每块板6个孔。晾干后,紫外照射1小时。3. After soaking the round fiber membranes of the two proteins cut in step 2 with 75% ethanol for 2 hours, respectively, take them out and spread them on the bottom of a 24-well plate and dry them. Collagen membranes were spread on 2 plates, each with 6 wells, and recombinant spider silk protein RepB5 membranes were spread on 2 plates, each with 6 wells. After air-drying, UV irradiation was performed for 1 hour.
4、L929细胞铺板4.L929 cell plating
将T75细胞培养瓶中的培养液吸出,PBS清洗一遍后,加入1mL胰酶,轻轻晃动培养瓶,使胰酶接触到整个细胞培养瓶底部所有细胞后,将胰酶吸出,将T75细胞培养瓶放至37℃,消化3min后取出培养瓶,观察细胞是否已经与细胞瓶底部分离。培养瓶中加入10mL含有10%FBS的1640培养基,轻轻吹打混匀后,将10mL细胞悬液吸出后加入到50mL离心管中,取少量细胞悬液于1.5ml离心管中,使用血球计数板进行计数。将其配置成4×10 4个/ml的细胞悬液。24孔板中,铺好膜的孔和未铺膜的孔,每孔加入200ul细胞悬液然后补加300μl培养基进行培养。 Aspirate the culture solution from the T75 cell culture flask. After washing it in PBS, add 1 mL of trypsin. Gently shake the culture flask to allow the trypsin to contact all the cells at the bottom of the cell culture flask. Then, aspirate the trypsin to culture the T75 cells. The flask was placed at 37 ° C. After 3 minutes of digestion, the culture flask was removed and the cells were separated from the bottom of the cell flask. 10 mL of 1640 medium containing 10% FBS was added to the culture flask. After gently pipetting, the 10 mL cell suspension was aspirated and added to a 50 mL centrifuge tube. A small amount of the cell suspension was placed in a 1.5 ml centrifuge tube. Use a blood cell count. Plates are counted. This was prepared as a cell suspension of 4 × 10 4 cells / ml. In a 24-well plate, wells with and without membranes are plated, and 200 ul of cell suspension is added to each well followed by 300 μl of medium for culture.
5、MSC细胞铺板5.MSC plating
将T75细胞培养瓶中的培养液吸出,PBS清洗一遍后,加入1mL胰酶,轻轻晃动培养瓶,使胰酶接触到整个细胞培养瓶底部所有细胞后,将胰酶吸出,将T75细胞培养瓶放至37℃,消化3min后取出培养瓶,观察细胞是否已经与细胞瓶底部分离。培养瓶中加入10mL含有10%FBS的DMEM/F-12培养基,轻轻吹打混匀后,将10mL细胞悬液吸出后加入到50mL离 心管中,取少量细胞悬液于1.5ml离心管中,使用血球计数板进行计数。将其配置成4×10 4个/ml的细胞悬液。24孔板中,铺好膜的孔和未铺膜的孔,每孔加入200ul细胞悬液然后补加300μl培养基进行培养。 Aspirate the culture solution from the T75 cell culture flask. After washing it in PBS, add 1 mL of trypsin. Gently shake the culture flask to allow the trypsin to contact all the cells at the bottom of the cell culture flask. Then, aspirate the trypsin to culture the T75 cells. The flask was placed at 37 ° C. After 3 minutes of digestion, the culture flask was removed and the cells were separated from the bottom of the cell flask. Add 10 mL of DMEM / F-12 medium containing 10% FBS to the culture flask. After gently pipetting, mix 10 mL of the cell suspension and add it to a 50 mL centrifuge tube. Take a small amount of the cell suspension into a 1.5 mL centrifuge tube. , Use a blood cell counting board for counting. This was prepared as a cell suspension of 4 × 10 4 cells / ml. In a 24-well plate, wells with and without membranes are plated, and 200 ul of cell suspension is added to each well followed by 300 μl of medium for culture.
6、细胞在牛跟腱胶原蛋白膜和蛛丝蛋白膜上细胞增殖情况检测6.Detection of cells on bovine Achilles tendon collagen film and spider silk protein film
第3,4,5天分别取出L929细胞1块24孔细胞培养板,使用显微镜进行观察并拍照,结果如图7所示,MSC细胞由于贴付在纤维膜上后会导致透光率下降而无法显微镜下成像,故而未拍照观测。从图7中可以看出,牛跟腱胶原蛋白膜和重组蜘蛛丝蛋白纤维膜均可以有效的实现L929的贴附,并且细胞形状良好。从增殖效果来看,对于重组蜘蛛丝蛋白纤维膜而言,其在L929和MSC细胞培养方面都表现出了明显优于胶原蛋白纤维膜的促增值作用。On the 3rd, 4th, and 5th days, one 24-well cell culture plate of L929 cells was taken out, observed and photographed with a microscope, and the results are shown in FIG. 7. As the MSC cells are attached to the fiber membrane, the light transmittance will decrease. Imaging was not possible under the microscope, so no photos were taken for observation. It can be seen from FIG. 7 that both the bovine Achilles tendon collagen film and the recombinant spider silk protein fiber film can effectively achieve the attachment of L929, and the cell shape is good. From the perspective of proliferation effect, for the recombinant spider silk protein fiber membrane, it showed significantly better value-added effect than the collagen fiber membrane in both L929 and MSC cell culture.
取出的24孔细胞培养板中,每孔吸出所有培养基,然后在每个孔中加入200ul培养基,再加入20ul CCK-8溶液,37℃孵育1h后,使用酶标仪,在450mm处进行读数,对结果进行统计,分析细胞增殖状况,结果如图8-1和8-2所示。In the removed 24-well cell culture plate, aspirate all the medium from each well, then add 200ul of culture medium to each well, add 20ul of CCK-8 solution, and incubate at 37 ° C for 1h. Use a microplate reader at 450mm Readings, statistics of the results, and analysis of cell proliferation, the results are shown in Figures 8-1 and 8-2.
因此可以判定,两种纤维膜相比,重组蜘蛛丝蛋白纤维膜可以更快的实现细胞的贴附和生长,因此具备良好的生物相容性。Therefore, it can be judged that, compared with the two kinds of fiber membranes, the recombinant spider silk protein fiber membrane can achieve cell attachment and growth faster, and therefore has good biocompatibility.
实施例7重组蜘蛛丝蛋白静电纺丝膜皮肤再生试验Example 7 Skin Regeneration Test of Recombinant Spider Silk Protein Electrospinning Film
皮肤创面修复与再生是静电纺丝纤维膜的一个重要的潜在应用领域,本发明人将静电纺丝法制备的重组蜘蛛丝蛋白纤维膜与天然胶原蛋白膜一起评价了其在皮肤创面修复中的作用,具体评价方法与结果如下:Skin wound repair and regeneration is an important potential field of application for electrospun fiber membranes. The inventors evaluated recombinant spider silk protein fiber membranes prepared with electrospinning method together with natural collagen membranes in skin wound repair. Role, specific evaluation methods and results are as follows:
动物模型建立:采用自身对照的方法,大鼠在脊柱两侧约0.5cm处等距离选3个直径为12mm的圆形区域,每点间隔1cm。大鼠按照3.0mL/kg的剂量腹腔注射10%水合氯醛溶液,待翻正反射消失后在剥离圆形区域的全层皮肤组织,覆盖供试品RepB5和牛跟腱胶原蛋白纤维膜。实验后连续3d每只注射2.0×10 3U/d的氨苄西林钠,以防感染。术后观察创面愈合情况,术后3周,大鼠行安乐死,采集手术部位数字图像,利用软件计算术部创面/无毛区域的面积,以考察各组样品促进创面愈合的作用,结果如图9所示。 Animal model establishment: Using the method of self-control, the rats selected three circular areas with a diameter of 12 mm at equal distances at about 0.5 cm on both sides of the spine, and each point was separated by 1 cm. Rats were injected intraperitoneally with a 10% chloral hydrate solution at a dose of 3.0 mL / kg. After the normal reflection disappeared, the full-thickness skin tissue was peeled off from the circular area and covered with the test product RepB5 and the bovine Achilles tendon collagen fiber membrane. After the experiment, each patient was injected with 2.0 × 10 3 U / d ampicillin sodium for 3 consecutive days to prevent infection. Wound healing was observed after surgery. Rats were euthanized at 3 weeks after operation. Digital images of the surgical site were collected and the area of the wound / hairless area of the surgical department was calculated using software to investigate the role of each group of samples in promoting wound healing. The results are shown in the figure below. 9 shown.
从皮肤创面修复与再生试验中可以看出重组蛛丝蛋白静电纺丝纤维膜的皮肤修复效果优于牛跟腱胶原蛋白纤维膜,手术后创面恢复更好。It can be seen from the skin wound repair and regeneration test that the skin repair effect of the recombinant spider silk protein electrospun fiber membrane is better than that of the bovine Achilles tendon collagen fiber membrane, and the wound recovery is better after surgery.
实施例8重组蜘蛛丝蛋白体外凝血试验Example 8 In vitro coagulation test of recombinant spider silk protein
目前市售比较高端的医用凝血产品包括粉状天然胶原蛋白,具备凝血快速和生物安全的特 点,因此本发明人还考察了与天然胶原蛋白相比重组蛛丝蛋白的体外凝血效果,方法如下:At present, the relatively high-end medical coagulation products on the market include powdered natural collagen, which has the characteristics of rapid coagulation and biosafety. Therefore, the inventors also investigated the in vitro coagulation effect of recombinant spider silk protein compared with natural collagen, as follows:
1、原材料获得:将重组蜘蛛丝蛋白冻干粉与牛跟腱胶原蛋白样品分别使用同样条件粉碎制粉,过50目筛,获得粒径基本一致的均一粉状供试品。1. Raw material acquisition: Reconstituted spider silk protein lyophilized powder and bovine Achilles tendon collagen samples were crushed and powdered under the same conditions, and passed through a 50-mesh sieve to obtain a uniform powdery test product with substantially uniform particle size.
2、将等质量的牛跟腱胶原蛋白粉、RepB5粉分别置于采血管中,抽真空;空白对照管直接抽真空,每样3管。2. Put equal-quality bovine Achilles tendon collagen powder and RepB5 powder in the blood collection tube and evacuate them respectively; the blank control tube is evacuated directly, 3 tubes each.
3、取11~12周年龄,普通级新西兰白兔1只,雌雄不限,体重1.8~2.2kg,家兔按照3.5mL/kg的剂量腹腔注射10%水合氯醛溶液,待翻正反射消失后通过颈总主动脉采集3ml血液至采各血管。待血液加入真空管后开始计时,室温下每隔约5s倾斜试管一次,至血液不再流动时停止计时,即得全血凝固时间。计算结果如图10所示。3. Take 11 to 12 weeks of age, one ordinary New Zealand white rabbit, male or female, weighing 1.8 to 2.2 kg, rabbits were injected intraperitoneally with a 10% chloral hydrate solution at a dose of 3.5 mL / kg, and the positive reflection disappeared after turning 3ml blood was collected through the common carotid aorta to each blood vessel. After the blood was added to the vacuum tube, the timing was started. At room temperature, the test tube was tilted every 5 seconds, and when the blood no longer flowed, the timing was stopped to obtain the whole blood coagulation time. The calculation results are shown in Figure 10.
从试管凝血试验结果可以看出,同样的试验条件下蛛丝蛋白RepB5所制备的蛋白粉凝血时间短于牛跟腱胶原蛋白粉末,因此判断具备良好的促凝血潜力。From the test tube coagulation test results, it can be seen that under the same test conditions, the protein powder prepared by the spider silk protein RepB5 has a shorter clotting time than the bovine Achilles tendon collagen powder, so it is judged that it has good procoagulant potential.

Claims (10)

  1. 重组蜘蛛丝蛋白,其氨基酸序列由N末端非重复区域、核心重复区域、C末端非重复区域组成,其中核心重复区域由1-30个RepA和/或1-15个RepB组成,单个RepA氨基酸序列如SEQ ID NO:1所示,单个RepB氨基酸序列如SEQ ID NO:2所示;所述N末端非重复区域,氨基酸序列如SEQ ID NO:3所示;所述C末端非重复区域,氨基酸序列如SEQ ID NO:4所示。Recombinant spider silk protein, the amino acid sequence of which consists of N-terminal non-repeating region, core repeating region, and C-terminal non-repeating region, wherein the core repeating region is composed of 1-30 RepA and / or 1-15 RepB, and a single RepA amino acid sequence As shown in SEQ ID NO: 1, the single RepB amino acid sequence is shown in SEQ ID NO: 2; the N-terminal non-repeating region, the amino acid sequence is shown in SEQ ID NO: 3; the C-terminal non-repeating region, the amino acid The sequence is shown in SEQ ID NO: 4.
  2. 根据权利要求1所述的重组蜘蛛丝蛋白,其特征在于:所述核心重复区域由5-30个RepA或5-15个RepB组成。The recombinant spider silk protein according to claim 1, wherein the core repeat region consists of 5-30 RepA or 5-15 RepB.
  3. 根据权利要求1所述的重组蜘蛛丝蛋白,其特征在于:所述核心重复区域由1-5个RepA和1-5个RepB的串联体组成。The recombinant spider silk protein according to claim 1, wherein the core repeat region is composed of 1-5 RepA and 1-5 RepB tandems.
  4. 根据权利要求3所述的重组蜘蛛丝蛋白,其特征在于:所述1-5个RepA的串联体位于整个融合蛋白的靠近N端位置,所述1-5个RepB的串联体位于整个融合蛋白的C端位置。The recombinant spider silk protein according to claim 3, wherein the tandem of 1-5 RepA is located near the N-terminus of the entire fusion protein, and the tandem of 1-5 RepB is located in the entire fusion protein C-position.
  5. 根据权利要求1至4任一项所述的重组蜘蛛丝蛋白,其特征在于:所述核心重复区域由5个RepA串联体、10个RepA串联体、20个RepA串联体、30个RepA串联体、5个RepB串联体、10个RepB串联体、15个RepB串联体、5个RepA加5个RepB串联体,或者2个RepA5RepB5的串联体组成。The recombinant spider silk protein according to any one of claims 1 to 4, wherein the core repeat region is composed of 5 RepA tandems, 10 RepA tandems, 20 RepA tandems, and 30 RepA tandems. , 5 RepB tandems, 10 RepB tandems, 15 RepB tandems, 5 RepA plus 5 RepB tandems, or 2 RepA5RepB5 tandems.
  6. 一种包含如权利要求5所述的核苷酸序列的载体。A vector comprising the nucleotide sequence according to claim 5.
  7. 一种包含如权利要求6所述的载体的大肠杆菌菌株。An E. coli strain comprising the vector of claim 6.
  8. 一种表达重组蜘蛛丝蛋白的方法,其特征在于包括如下步骤:A method for expressing a recombinant spider silk protein, comprising the following steps:
    (1)将如权利要求7所述的大肠杆菌菌落接入发酵罐中,设定发酵温度为37℃、pH为6.8-7.2之间、DO设定在30-40%之间;(1) The E. coli colony according to claim 7 is inserted into a fermentation tank, and the fermentation temperature is set to 37 ° C, the pH is between 6.8-7.2, and the DO is set between 30-40%;
    (2)发酵开始后定期取样进行OD600和菌体湿重的测定,待DO曲线出现急剧上升时,开始进行补料培养,补料培养基的流加速度维持在8-12g/L/h;(2) After the start of fermentation, take regular samples to measure the OD600 and the wet weight of the bacteria. When the DO curve rises sharply, start feeding culture, and the flow acceleration of the feeding medium is maintained at 8-12g / L / h;
    (3)待菌体生长至OD600≈45-55之间,降低发酵温度至25-30℃,待温度稳定后向发酵罐中加入终浓度为0.2-1.0mM的IPTG进行诱导表达;诱导表达8-12h结束培养。(3) When the bacterial cells grow to between OD600≈45-55, reduce the fermentation temperature to 25-30 ° C. After the temperature is stabilized, add IPTG with a final concentration of 0.2-1.0mM to the fermentation tank to induce expression; The culture was terminated at -12h.
  9. 一种重组蜘蛛丝蛋白的纯化方法,其特征在于包括如下步骤:A method for purifying recombinant spider silk protein, comprising the following steps:
    (1)取表达重组蜘蛛丝蛋白的大肠杆菌,经菌体破碎、收集裂解物上清液;(1) Take E. coli expressing recombinant spider silk protein, crush the cells, and collect the lysate supernatant;
    (2)取上述裂解物上清液膜过滤去杂;(2) take the above lysate supernatant membrane and filter to remove impurities;
    (3)IMAC亲和层析纯化即得目的蛋白。(3) The target protein can be obtained by purification by IMAC affinity chromatography.
  10. 如权利要求1至5任一项所述的重组蜘蛛丝蛋白在制作蛋白类缝合线、蛋白类生物修复膜、蛋白类止血材料中的应用。The application of the recombinant spider silk protein according to any one of claims 1 to 5 in the production of protein sutures, protein bioremediation membranes, and protein hemostatic materials.
PCT/CN2018/094616 2018-06-22 2018-07-05 Recombinant spider silk proteins, preparation method therefor and industrial application thereof WO2019242047A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201810648563.X 2018-06-22
CN201810648563.XA CN110627889B (en) 2018-06-22 2018-06-22 Recombinant spider silk protein, preparation method and industrial application thereof

Publications (1)

Publication Number Publication Date
WO2019242047A1 true WO2019242047A1 (en) 2019-12-26

Family

ID=68966814

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2018/094616 WO2019242047A1 (en) 2018-06-22 2018-07-05 Recombinant spider silk proteins, preparation method therefor and industrial application thereof

Country Status (2)

Country Link
CN (1) CN110627889B (en)
WO (1) WO2019242047A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114805847A (en) * 2022-03-09 2022-07-29 上海交通大学 Purification based on spider silk-cationic polypeptide fusion protein and preparation method of underwater adhesion hydrogel

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103827139A (en) * 2011-11-02 2014-05-28 丝芭博株式会社 Polypeptide solution, artificial polypeptide fiber production method using same, and polypeptide refining method
CN103833838A (en) * 2012-11-22 2014-06-04 中国科学院青岛生物能源与过程研究所 High-performance spider-silk-like protein material and its biosynthesis method
WO2015042164A2 (en) * 2013-09-17 2015-03-26 Refactored Materials, Inc. Methods and compositions for synthesizing improved silk fibers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1322124C (en) * 2003-05-26 2007-06-20 清华大学 Gene of coding cobweb protein and use thereof
KR20070059065A (en) * 2004-07-22 2007-06-11 테크니쉐 유니베르시테트 뮌헨 Recombinant spider silk proteins
CN107805283B (en) * 2017-11-10 2021-01-15 井冈山大学 Cobweb-like protein and biosynthesis method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103827139A (en) * 2011-11-02 2014-05-28 丝芭博株式会社 Polypeptide solution, artificial polypeptide fiber production method using same, and polypeptide refining method
CN103833838A (en) * 2012-11-22 2014-06-04 中国科学院青岛生物能源与过程研究所 High-performance spider-silk-like protein material and its biosynthesis method
WO2015042164A2 (en) * 2013-09-17 2015-03-26 Refactored Materials, Inc. Methods and compositions for synthesizing improved silk fibers

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BROOKS, A. E. ET AL.: "Properties of Synthetic Spider Silk Fibers Based on Argiope Aurantia MaSp2", BIOMACROMOLECULES, vol. 9, no. 6, 5 June 2008 (2008-06-05), pages 1506 - 1510, XP055446845, DOI: 10.1021/bm701124p *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114805847A (en) * 2022-03-09 2022-07-29 上海交通大学 Purification based on spider silk-cationic polypeptide fusion protein and preparation method of underwater adhesion hydrogel
CN114805847B (en) * 2022-03-09 2024-03-19 上海交通大学 Purification of spider silk-cation polypeptide fusion protein-based and preparation method of underwater adhesion hydrogel

Also Published As

Publication number Publication date
CN110627889A (en) 2019-12-31
CN110627889B (en) 2022-05-27

Similar Documents

Publication Publication Date Title
JP7411858B2 (en) Recombinant human collagen type XVII, preparation method, and use
CN110845603B (en) Human collagen 17-type polypeptide, production method and use thereof
CN108456246B (en) Recombinant spider silk protein, preparation method and application thereof
WO2017206326A1 (en) Recombinant human collagen, and coding gene and manufacturing method thereof
CN110606896A (en) Recombinant human III-type collagen alpha 1 chain and application thereof
CN114106150B (en) Recombinant collagen, preparation method and application thereof
CN113683679B (en) Recombinant I-type humanized collagen C1L6T and preparation method and application thereof
CN113683680B (en) Recombinant I-type humanized collagen C1L1T and preparation method and application thereof
CN115521373B (en) Triple helix recombinant humanized type I collagen, preparation method and application thereof
CN111393531A (en) Subunit fusion protein CD2V-Fc and preparation method and application thereof
CN116574172B (en) Recombinant humanized type I collagen and preparation method thereof
CN112745385B (en) Recombinant humanized collagen, industrial preparation method and product application thereof
CN116082493B (en) High-stability recombinant collagen, construction method and application thereof
RU2478706C1 (en) Method of producing suspensions of hydrogel microparticles with given dimensions based on recombinant cobweb protein and use thereof
JP2024050477A (en) Recombinant humanized collagen and its applications
WO2019242047A1 (en) Recombinant spider silk proteins, preparation method therefor and industrial application thereof
CN110468143B (en) Preparation method and application of antibacterial peptide NZX
CN107365789A (en) A kind of preparation method of recombinant spider silk protein nano fibrous membrane
CN101831452B (en) Method for efficiently expressing and producing T4 lysozyme through recombinant trichoderma reesei in inductive mode
CN113788891B (en) Recombinant I-type humanized collagen C1L4T and preparation method and application thereof
CN114908034B (en) Acellular fluid, acellular matrix hydrogel, and preparation methods and application thereof
CN110101908B (en) Degradable tissue repair material and preparation method thereof
CN113683678B (en) Recombinant I-type humanized collagen C1L2T and preparation method and application thereof
CN117025655B (en) Gene expression vector, genetically engineered bacterium and method for improving yield of humanized III type recombinant collagen and application
CN117466992A (en) Fibronectin mutant and preparation and application thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18923130

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18923130

Country of ref document: EP

Kind code of ref document: A1